BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xia H, Mao Q, Paulson HL, Davidson BL. siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol. 2002;20:1006-1010. [PMID: 12244328 DOI: 10.1038/nbt739] [Cited by in Crossref: 645] [Cited by in F6Publishing: 561] [Article Influence: 33.9] [Reference Citation Analysis]
Number Citing Articles
1 Holen T, Mobbs C. Lobotomy of genes: use of RNA interference in Neuroscience. Neuroscience 2004;126:1-7. [DOI: 10.1016/j.neuroscience.2004.03.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
2 Berke SJS, Paulson HL. Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration. Current Opinion in Genetics & Development 2003;13:253-61. [DOI: 10.1016/s0959-437x(03)00053-4] [Cited by in Crossref: 130] [Cited by in F6Publishing: 51] [Article Influence: 7.2] [Reference Citation Analysis]
3 Wilson JA, Jayasena S, Khvorova A, Sabatinos S, Rodrigue-Gervais IG, Arya S, Sarangi F, Harris-Brandts M, Beaulieu S, Richardson CD. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc Natl Acad Sci USA. 2003;100:2783-2788. [PMID: 12594341 DOI: 10.1073/pnas.252758799] [Cited by in Crossref: 218] [Cited by in F6Publishing: 193] [Article Influence: 12.1] [Reference Citation Analysis]
4 Toyoda K, Chu Y, Heistad DD. Gene therapy for cerebral vascular disease: update 2003. Br J Pharmacol 2003;139:1-9. [PMID: 12746217 DOI: 10.1038/sj.bjp.0705217] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
5 Shi L, Luo K, Xia D, Chen T, Chen G, Jiang Y, Li N, Cao X. DIgR2, dendritic cell-derived immunoglobulin receptor 2, is one representative of a family of IgSF inhibitory receptors and mediates negative regulation of dendritic cell-initiated antigen-specific T-cell responses. Blood 2006;108:2678-86. [DOI: 10.1182/blood-2006-04-015404] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
6 Lamontagne B, Abou Elela S. Short RNA guides cleavage by eukaryotic RNase III. PLoS One 2007;2:e472. [PMID: 17534422 DOI: 10.1371/journal.pone.0000472] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
7 Harper SQ, Staber PD, He X, Eliason SL, Martins IH, Mao Q, Yang L, Kotin RM, Paulson HL, Davidson BL. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc Natl Acad Sci USA. 2005;102:5820-5825. [PMID: 15811941 DOI: 10.1073/pnas.0501507102] [Cited by in Crossref: 466] [Cited by in F6Publishing: 427] [Article Influence: 29.1] [Reference Citation Analysis]
8 Nickson P, Toth A, Erhardt P. PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress. Cardiovasc Res. 2007;73:48-56. [PMID: 17107669 DOI: 10.1016/j.cardiores.2006.10.001] [Cited by in Crossref: 101] [Cited by in F6Publishing: 96] [Article Influence: 6.7] [Reference Citation Analysis]
9 Leonard JN, Schaffer DV. Antiviral RNAi therapy: emerging approaches for hitting a moving target. Gene Ther 2006;13:532-40. [PMID: 16177819 DOI: 10.1038/sj.gt.3302645] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 4.5] [Reference Citation Analysis]
10 Ge Q, Ilves H, Dallas A, Kumar P, Shorenstein J, Kazakov SA, Johnston BH. Minimal-length short hairpin RNAs: the relationship of structure and RNAi activity. RNA 2010;16:106-17. [PMID: 19952116 DOI: 10.1261/rna.1894510] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
11 Weatherford ET, Liu X, Sigmund CD. Regulation of renin expression by the orphan nuclear receptors Nr2f2 and Nr2f6. Am J Physiol Renal Physiol 2012;302:F1025-33. [PMID: 22278040 DOI: 10.1152/ajprenal.00362.2011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
12 Helmlinger D, Abou-Sleymane G, Yvert G, Rousseau S, Weber C, Trottier Y, Mandel JL, Devys D. Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model. J Neurosci 2004;24:1881-7. [PMID: 14985428 DOI: 10.1523/JNEUROSCI.4407-03.2004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
13 Shen Y, Senzer N, Nemunaitis J. Individualised cancer therapeutics: dream or reality? Therapeutics construction. Expert Opinion on Biological Therapy 2005;5:1427-41. [DOI: 10.1517/14712598.5.11.1427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Lu A, Zhang H, Zhang X, Wang H, Hu Q, Shen L, Schaffhausen BS, Hou W, Li L. Attenuation of SARS coronavirus by a short hairpin RNA expression plasmid targeting RNA-dependent RNA polymerase. Virology 2004;324:84-9. [PMID: 15183056 DOI: 10.1016/j.virol.2004.03.031] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
15 Li LH, He J, Hua D, Guo ZJ, Gao Q. Lentivirus-mediated inhibition of Med19 suppresses growth of breast cancer cells in vitro. Cancer Chemother Pharmacol 2011;68:207-15. [PMID: 20890603 DOI: 10.1007/s00280-010-1468-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
16 Shoji M, Chuma S, Yoshida K, Morita T, Nakatsuji N. RNA interference during spermatogenesis in mice. Dev Biol 2005;282:524-34. [PMID: 15950615 DOI: 10.1016/j.ydbio.2005.03.030] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
17 Röhl T, Kurreck J. RNA interference in pain research. J Neurochem 2006;99:371-80. [DOI: 10.1111/j.1471-4159.2006.04082.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
18 Cheng K, Mahato RI. Gene modulation for treating liver fibrosis. Crit Rev Ther Drug Carrier Syst. 2007;24:93-146. [PMID: 17725523 DOI: 10.1615/critrevtherdrugcarriersyst.v24.i2.10] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
19 Malphettes L, Schoenmakers RG, Fussenegger M. 6-hydroxy-nicotine-inducible multilevel transgene control in mammalian cells. Metab Eng 2006;8:543-53. [PMID: 16962351 DOI: 10.1016/j.ymben.2006.07.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
20 Hua R, Wang Y, Lian W, Li W, Xi Y, Xue S, Kang T, Lei M. Small RNA-seq analysis of extracellular vesicles from porcine uterine flushing fluids during peri-implantation. Gene 2021;766:145117. [PMID: 32920039 DOI: 10.1016/j.gene.2020.145117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Boudreau RL, Monteys AM, Davidson BL. Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs. RNA 2008;14:1834-44. [PMID: 18697922 DOI: 10.1261/rna.1062908] [Cited by in Crossref: 102] [Cited by in F6Publishing: 97] [Article Influence: 7.8] [Reference Citation Analysis]
22 Fan R, Li X, Du W, Zou X, Du R, Zhao L, Luo G, Mo P, Xia L, Pan Y. Adenoviral-mediated RNA interference targeting URG11 inhibits growth of human hepatocellular carcinoma. Int J Cancer. 2011;128:2980-2993. [PMID: 20725996 DOI: 10.1002/ijc.25624] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
23 Sioud M. Therapeutic siRNAs. Trends Pharmacol Sci 2004;25:22-8. [PMID: 14723975 DOI: 10.1016/j.tips.2003.11.006] [Cited by in Crossref: 101] [Cited by in F6Publishing: 84] [Article Influence: 5.9] [Reference Citation Analysis]
24 Zhang Y, Boado RJ, Pardridge WM. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats. J Gene Med 2003;5:1039-45. [PMID: 14661179 DOI: 10.1002/jgm.449] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 4.8] [Reference Citation Analysis]
25 Morris MC, Deshayes S, Heitz F, Divita G. Cell-penetrating peptides: from molecular mechanisms to therapeutics. Biol Cell. 2008;100:201-217. [PMID: 18341479 DOI: 10.1042/BC20070116] [Cited by in Crossref: 257] [Cited by in F6Publishing: 97] [Article Influence: 19.8] [Reference Citation Analysis]
26 Peterson JR, Burmeister MA, Tian X, Zhou Y, Guruju MR, Stupinski JA, Sharma RV, Davisson RL. Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II. Hypertension 2009;54:1106-14. [PMID: 19805637 DOI: 10.1161/HYPERTENSIONAHA.109.140087] [Cited by in Crossref: 78] [Cited by in F6Publishing: 58] [Article Influence: 6.5] [Reference Citation Analysis]
27 Schaniel C, Lee DF, Lemischka IR. Exploration of self-renewal and pluripotency in ES cells using RNAi. Methods Enzymol 2010;477:351-65. [PMID: 20699150 DOI: 10.1016/S0076-6879(10)77018-X] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
28 Liu X, Howard KA, Dong M, Andersen MØ, Rahbek UL, Johnsen MG, Hansen OC, Besenbacher F, Kjems J. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 2007;28:1280-8. [DOI: 10.1016/j.biomaterials.2006.11.004] [Cited by in Crossref: 286] [Cited by in F6Publishing: 243] [Article Influence: 20.4] [Reference Citation Analysis]
29 Huang P, Frohman MA. The potential for phospholipase D as a new therapeutic target. Expert Opin Ther Targets 2007;11:707-16. [PMID: 17465727 DOI: 10.1517/14728222.11.5.707] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
30 Ebbesen M, Jensen TG, Andersen S, Pedersen FS. Ethical perspectives on RNA interference therapeutics. Int J Med Sci 2008;5:159-68. [PMID: 18612370 DOI: 10.7150/ijms.5.159] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
31 Tan PH, Yu SW, Lin VC, Liu CC, Chien CC. RNA interference-mediated gene silence of the NR1 subunit of the NMDA receptor by subcutaneous injection of vector-encoding short hairpin RNA reduces formalin-induced nociception in the rat. Pain 2011;152:573-81. [PMID: 21239115 DOI: 10.1016/j.pain.2010.11.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
32 Kim WJ, Christensen LV, Jo S, Yockman JW, Jeong JH, Kim Y, Kim SW. Cholesteryl Oligoarginine Delivering Vascular Endothelial Growth Factor siRNA Effectively Inhibits Tumor Growth in Colon Adenocarcinoma. Molecular Therapy 2006;14:343-50. [DOI: 10.1016/j.ymthe.2006.03.022] [Cited by in Crossref: 196] [Cited by in F6Publishing: 182] [Article Influence: 13.1] [Reference Citation Analysis]
33 Liu YP, Berkhout B. miRNA cassettes in viral vectors: problems and solutions. Biochim Biophys Acta 2011;1809:732-45. [PMID: 21679781 DOI: 10.1016/j.bbagrm.2011.05.014] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 5.7] [Reference Citation Analysis]
34 Ulusoy A, Sahin G, Björklund T, Aebischer P, Kirik D. Dose optimization for long-term rAAV-mediated RNA interference in the nigrostriatal projection neurons. Mol Ther 2009;17:1574-84. [PMID: 19584816 DOI: 10.1038/mt.2009.142] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
35 Sui D, Wilson JE. Selective depletion of the Type I, Type II, and Type III isozymes of hexokinase in mammalian cells using small interfering RNAs. Biochem Biophys Res Commun 2004;319:768-73. [PMID: 15184049 DOI: 10.1016/j.bbrc.2004.04.198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
36 Cheng G, Danquah M, Mahato RI. MicroRNAs as Therapeutic Targets for Cancer. In: Lu Y, Mahato RI, editors. Pharmaceutical Perspectives of Cancer Therapeutics. New York: Springer US; 2009. pp. 441-74. [DOI: 10.1007/978-1-4419-0131-6_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Davidson BL, Breakefield XO. Viral vectors for gene delivery to the nervous system. Nat Rev Neurosci 2003;4:353-64. [DOI: 10.1038/nrn1104] [Cited by in Crossref: 228] [Cited by in F6Publishing: 196] [Article Influence: 12.7] [Reference Citation Analysis]
38 Ying SY, Lin SL. Current perspectives in intronic micro RNAs (miRNAs). J Biomed Sci. 2006;13:5-15. [PMID: 16228283 DOI: 10.1007/s11373-005-9036-8] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 3.8] [Reference Citation Analysis]
39 Hassan A, Tian Y, Zheng W, Ji H, Sandberg K, Verbalis JG. Small interfering RNA-mediated functional silencing of vasopressin V 2 receptors in the mouse kidney. Physiological Genomics 2005;21:382-8. [DOI: 10.1152/physiolgenomics.00147.2004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
40 Takabatake Y, Isaka Y, Mizui M, Kawachi H, Shimizu F, Ito T, Hori M, Imai E. Exploring RNA interference as a therapeutic strategy for renal disease. Gene Ther 2005;12:965-73. [PMID: 15729369 DOI: 10.1038/sj.gt.3302480] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 4.0] [Reference Citation Analysis]
41 Prabhu R, Vittal P, Yin Q, Flemington E, Garry R, Robichaux WH, Dash S. Small interfering RNA effectively inhibits protein expression and negative strand RNA synthesis from a full-length hepatitis C virus clone. J Med Virol 2005;76:511-9. [DOI: 10.1002/jmv.20391] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
42 Cho KA, Ryu SJ, Park JS, Jang IS, Ahn JS, Kim KT, Park SC. Senescent phenotype can be reversed by reduction of caveolin status. J Biol Chem 2003;278:27789-95. [PMID: 12730243 DOI: 10.1074/jbc.M208105200] [Cited by in Crossref: 87] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
43 Hilleman MR. Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine. 2003;21:4626-4649. [PMID: 14585670 DOI: 10.1016/s0264-410x(03)00529-2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
44 Kalozoumi G, Yacoub M, Sanoudou D. MicroRNAs in heart failure: Small molecules with major impact. Glob Cardiol Sci Pract. 2014;2014:79-102. [PMID: 25419522 DOI: 10.5339/gcsp.2014.30] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
45 Xia XG, Zhou H, Samper E, Melov S, Xu Z. Pol II-expressed shRNA knocks down Sod2 gene expression and causes phenotypes of the gene knockout in mice. PLoS Genet 2006;2:e10. [PMID: 16450009 DOI: 10.1371/journal.pgen.0020010] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
46 Izzard L, Dlugolenski D, Xia Y, McMahon M, Middleton D, Tripp RA, Stambas J. Enhanced immunogenicity following miR-155 incorporation into the influenza A virus genome. Virus Res 2017;235:115-20. [PMID: 28392443 DOI: 10.1016/j.virusres.2017.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
47 Crittenden JR, Heidersbach A, Mcmanus MT. Lentiviral Strategies for RNAi Knockdown of Neuronal Genes. Current Protocols in Neuroscience 2007;39. [DOI: 10.1002/0471142301.ns0526s39] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
48 Kurreck J. Antisense technologies. Improvement through novel chemical modifications. Eur J Biochem. 2003;270:1628-1644. [PMID: 12694176 DOI: 10.1046/j.1432-1033.2003.03555.x] [Cited by in Crossref: 700] [Cited by in F6Publishing: 615] [Article Influence: 38.9] [Reference Citation Analysis]
49 Shan TZ, Ren Y, Wu T, Liu CX, Wang YZ. Regulatory role of Sirt1 on the gene expression of fatty acid-binding protein 3 in cultured porcine adipocytes. J Cell Biochem 2009;107:984-91. [DOI: 10.1002/jcb.22203] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
50 Xia H, Mao Q, Eliason SL, Harper SQ, Martins IH, Orr HT, Paulson HL, Yang L, Kotin RM, Davidson BL. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med. 2004;10:816-820. [PMID: 15235598 DOI: 10.1038/nm1076] [Cited by in Crossref: 472] [Cited by in F6Publishing: 411] [Article Influence: 27.8] [Reference Citation Analysis]
51 Maczuga P, Koornneef A, Borel F, Petry H, van Deventer S, Ritsema T, Konstantinova P. Optimization and comparison of knockdown efficacy between polymerase II expressed shRNA and artificial miRNA targeting luciferase and Apolipoprotein B100. BMC Biotechnol 2012;12:42. [PMID: 22827812 DOI: 10.1186/1472-6750-12-42] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
52 Bockamp E, Sprengel R, Eshkind L, Lehmann T, Braun JM, Emmrich F, Hengstler JG. Conditional transgenic mouse models: from the basics to genome-wide sets of knockouts and current studies of tissue regeneration. Regenerative Medicine 2008;3:217-35. [DOI: 10.2217/17460751.3.2.217] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
53 Rhee SW, Stimers JR, Wang W, Pang L. Vascular smooth muscle-specific knockdown of the noncardiac form of the L-type calcium channel by microRNA-based short hairpin RNA as a potential antihypertensive therapy. J Pharmacol Exp Ther 2009;329:775-82. [PMID: 19244098 DOI: 10.1124/jpet.108.148866] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
54 Jiang W. Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice. Vaccine 2012;30:758-66. [PMID: 22133510 DOI: 10.1016/j.vaccine.2011.11.076] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
55 Rye PD, Stigbrand T. Interfering with cancer: a brief outline of advances in RNA interference in oncology. Tumour Biol 2004;25:329-36. [PMID: 15627900 DOI: 10.1159/000081403] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
56 Lombardi MS, Jaspers L, Spronkmans C, Gellera C, Taroni F, Di Maria E, Donato SD, Kaemmerer WF. A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference. Exp Neurol 2009;217:312-9. [PMID: 19289118 DOI: 10.1016/j.expneurol.2009.03.004] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 7.3] [Reference Citation Analysis]
57 Jarad G, Simske JS, Sedor JR, Schelling JR. Nucleic acid-based techniques for post-transcriptional regulation of molecular targets. Curr Opin Nephrol Hypertens 2003;12:415-21. [PMID: 12815338 DOI: 10.1097/00041552-200307000-00010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
58 Greber D, El-Baba MD, Fussenegger M. Intronically encoded siRNAs improve dynamic range of mammalian gene regulation systems and toggle switch. Nucleic Acids Res 2008;36:e101. [PMID: 18632760 DOI: 10.1093/nar/gkn443] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
59 Narvaiza I, Aparicio O, Vera M, Razquin N, Bortolanza S, Prieto J, Fortes P. Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing. J Virol 2006;80:12236-47. [PMID: 17020948 DOI: 10.1128/JVI.01205-06] [Cited by in Crossref: 43] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
60 Wells DK, Kath WL, Motter AE. Control of Stochastic and Induced Switching in Biophysical Networks. Phys Rev X 2015;5:031036. [PMID: 26451275 DOI: 10.1103/PhysRevX.5.031036] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
61 Lerner SP, Au JL. Risk-adapted use of intravesical chemotherapy. BJU Int 2008;102:1247-53. [PMID: 19035889 DOI: 10.1111/j.1464-410X.2008.07967.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
62 Takahashi Y, Nishikawa M, Kobayashi N, Takakura Y. Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases. J Control Release. 2005;105:332-343. [PMID: 15936841 DOI: 10.1016/j.jconrel.2005.04.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
63 Keiser MS, Kordower JH, Gonzalez-Alegre P, Davidson BL. Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy. Brain 2015;138:3555-66. [PMID: 26490326 DOI: 10.1093/brain/awv292] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
64 Chen M, Du Q, Zhang HY, Wang X, Liang Z. High-throughput screening using siRNA (RNAi) libraries. Expert Rev Mol Diagn 2007;7:281-91. [PMID: 17489735 DOI: 10.1586/14737159.7.3.281] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
65 Das DS, Wadhwa N, Kunj N, Sarda K, Pradhan BS, Majumdar SS. Dickkopf homolog 3 (DKK3) plays a crucial role upstream of WNT/β-CATENIN signaling for Sertoli cell mediated regulation of spermatogenesis. PLoS One 2013;8:e63603. [PMID: 23667645 DOI: 10.1371/journal.pone.0063603] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
66 March JC, Bentley WE. Engineering eukaryotic signal transduction with RNAi: EnhancingDrosophila S2 cell growth and recombinant protein synthesis via silencing ofTSC1. Biotechnol Bioeng 2006;95:645-52. [DOI: 10.1002/bit.20951] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
67 Unwalla H, Rossi JJ. Tat-regulated expression of RNA interference: triggers for the treatment of HIV infection. Curr HIV/AIDS Rep 2008;5:40-3. [PMID: 18417034 DOI: 10.1007/s11904-008-0007-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Pache L, König R, Chanda SK. Identifying HIV-1 host cell factors by genome-scale RNAi screening. Methods 2011;53:3-12. [PMID: 20654720 DOI: 10.1016/j.ymeth.2010.07.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
69 Sawada T, Abe M, Kai K, Kubota K, Fuchinoue S, Teraoka S. beta6 integrin is up-regulated in chronic renal allograft dysfunction. Clin Transplant 2004;18:525-8. [DOI: 10.1111/j.1399-0012.2004.00199.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
70 Lin SL, Miller JD, Ying SY. Intronic microRNA (miRNA). J Biomed Biotechnol 2006;2006:26818. [PMID: 17057362 DOI: 10.1155/JBB/2006/26818] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
71 Mullan B, Dugué C, Moutard V, Raoux D, Tremp G, Denèfle P, Perricaudet M, Robert J. Robust functional gene validation by adenoviral vectors: one-step Escherichia coli-Derived Recombinant Adenoviral Genome construction. Gene Ther 2004;11:1599-605. [DOI: 10.1038/sj.gt.3302333] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
72 Yoo JY, Kim J, Kim J, Huang J, Zhang SN, Kang Y, Kim H, Yun C. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition. Gene Ther 2008;15:635-51. [DOI: 10.1038/gt.2008.3] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
73 Huang M, Jia FJ, Yan YC, Guo LH, Li YP. Transactivated minimal E1b promoter is capable of driving the expression of short hairpin RNA. J Virol Methods 2006;134:48-54. [PMID: 16386806 DOI: 10.1016/j.jviromet.2005.11.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
74 Xie N, Liu S, Yang X, He X, Huang J, Wang K. DNA tetrahedron nanostructures for biological applications: biosensors and drug delivery. Analyst 2017;142:3322-32. [DOI: 10.1039/c7an01154g] [Cited by in Crossref: 69] [Cited by in F6Publishing: 11] [Article Influence: 17.3] [Reference Citation Analysis]
75 Ma WH, Liu YC, Xue ML, Zheng Z, Ge YL. Downregulation of survivin expression exerts antitumoral effects on mouse breast cancer cells in vitro and in vivo. Oncol Lett 2016;11:159-67. [PMID: 26870183 DOI: 10.3892/ol.2015.3870] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
76 Suzuki H, Tamai N, Habu Y, Chang MO, Takaku H. Suppression of hepatitis C virus replication by baculovirus vector-mediated short-hairpin RNA expression. FEBS Lett 2008;582:3085-9. [PMID: 18692048 DOI: 10.1016/j.febslet.2008.07.056] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
77 Sumimoto H, Miyagishi M, Miyoshi H, Yamagata S, Shimizu A, Taira K, Kawakami Y. Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference. Oncogene 2004;23:6031-9. [PMID: 15208655 DOI: 10.1038/sj.onc.1207812] [Cited by in Crossref: 145] [Cited by in F6Publishing: 114] [Article Influence: 9.1] [Reference Citation Analysis]
78 Doğaner F, Turgut Coşan D, Güneş HV, Değirmenci I, Bal C. The effects of p38 gene silencing on breast cancer cells. Mol Biol Rep 2014;41:2923-7. [PMID: 24464183 DOI: 10.1007/s11033-014-3148-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
79 Davisson RL. Physiological genomic analysis of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 2003;285:R498-511. [PMID: 12909574 DOI: 10.1152/ajpregu.00190.2003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 3.7] [Reference Citation Analysis]
80 Menn DJ, Pradhan S, Kiani S, Wang X. Fluorescent Guide RNAs Facilitate Development of Layered Pol II-Driven CRISPR Circuits. ACS Synth Biol 2018;7:1929-36. [PMID: 30021068 DOI: 10.1021/acssynbio.8b00153] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
81 Dorn G, Patel S, Wotherspoon G, Hemmings-Mieszczak M, Barclay J, Natt FJ, Martin P, Bevan S, Fox A, Ganju P, Wishart W, Hall J. siRNA relieves chronic neuropathic pain. Nucleic Acids Res 2004;32:e49. [PMID: 15026538 DOI: 10.1093/nar/gnh044] [Cited by in Crossref: 283] [Cited by in F6Publishing: 263] [Article Influence: 16.6] [Reference Citation Analysis]
82 Kunath T. Transgenic RNA interference to investigate gene function in the mouse. Methods Mol Biol 2008;461:165-86. [PMID: 19030796 DOI: 10.1007/978-1-60327-483-8_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Shan T, Wu T, Reng Y, Wang Y. Breed difference and regulation of the porcine adipose triglyceride lipase and hormone sensitive lipase by TNF��. Animal Genetics 2009;40:863-70. [DOI: 10.1111/j.1365-2052.2009.01927.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
84 Unwalla HJ, Li M, Kim JD, Li HT, Ehsani A, Alluin J, Rossi JJ. Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA. Nat Biotechnol 2004;22:1573-8. [DOI: 10.1038/nbt1040] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 3.8] [Reference Citation Analysis]
85 Mao Y, Mello C, Lamarcq L, Scherer B, Quinn T, Wong P, Farmer A. Viral delivery of shRNA. In: Appasani K, editor. RNA Interference Technology. Cambridge University Press; 2009. pp. 161-73. [DOI: 10.1017/cbo9780511546402.014] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 Lee K, Jang B, Lee YR, Suh EY, Yoo JS, Lee MJ, Lee JY, Lee H. The cutting-edge technologies of siRNA delivery and their application in clinical trials. Arch Pharm Res 2018;41:867-74. [PMID: 30136248 DOI: 10.1007/s12272-018-1069-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
87 Moore A, Medarova Z. Imaging of siRNA delivery and silencing. Methods Mol Biol 2009;487:93-110. [PMID: 19301644 DOI: 10.1007/978-1-60327-547-7_5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
88 Davidson BL, Paulson HL. Molecular medicine for the brain: silencing of disease genes with RNA interference. The Lancet Neurology 2004;3:145-9. [DOI: 10.1016/s1474-4422(04)00678-7] [Cited by in Crossref: 87] [Cited by in F6Publishing: 26] [Article Influence: 5.1] [Reference Citation Analysis]
89 Walton A, Sheehan MJ, Toth AL. Going wild for functional genomics: RNA interference as a tool to study gene-behavior associations in diverse species and ecological contexts. Hormones and Behavior 2020;124:104774. [DOI: 10.1016/j.yhbeh.2020.104774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
90 Miller VM, Paulson HL, Gonzalez-Alegre P. RNA interference in neuroscience: progress and challenges. Cell Mol Neurobiol 2005;25:1195-207. [PMID: 16388332 DOI: 10.1007/s10571-005-8447-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
91 Yang W, Paschen W. Conditional gene silencing in mammalian cells mediated by a stress-inducible promoter. Biochem Biophys Res Commun 2008;365:521-7. [PMID: 18021742 DOI: 10.1016/j.bbrc.2007.11.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
92 Godfrey A, Laman H, Boshoff C. RNA interference: a potential tool against Kaposiʼs sarcoma-associated herpesvirus: . Current Opinion in Infectious Diseases 2003;16:593-600. [DOI: 10.1097/00001432-200312000-00013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
93 Akaneya Y, Jiang B, Tsumoto T. RNAi-Induced Gene Silencing by Local Electroporation in Targeting Brain Region. Journal of Neurophysiology 2005;93:594-602. [DOI: 10.1152/jn.00161.2004] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 5.2] [Reference Citation Analysis]
94 Locarnini S. Therapies for hepatitis B: where to from here? Gastroenterology. 2005;128:789-792. [PMID: 15765416 DOI: 10.1053/j.gastro.2005.01.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
95 Bisht B, Srinivasan K, Dey CS. In vivo inhibition of focal adhesion kinase causes insulin resistance. J Physiol 2008;586:3825-37. [PMID: 18587052 DOI: 10.1113/jphysiol.2008.157107] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
96 Kuo CH, Ying SY. Advances in microRNA-mediated reprogramming technology. Stem Cells Int 2012;2012:823709. [PMID: 22550519 DOI: 10.1155/2012/823709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
97 Iwamoto M, Björklund T, Lundberg C, Kirik D, Wandless TJ. A general chemical method to regulate protein stability in the mammalian central nervous system. Chem Biol 2010;17:981-8. [PMID: 20851347 DOI: 10.1016/j.chembiol.2010.07.009] [Cited by in Crossref: 233] [Cited by in F6Publishing: 178] [Article Influence: 23.3] [Reference Citation Analysis]
98 Logan S, Arzua T, Canfield SG, Seminary ER, Sison SL, Ebert AD, Bai X. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models. Compr Physiol 2019;9:565-611. [PMID: 30873582 DOI: 10.1002/cphy.c180025] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 17.0] [Reference Citation Analysis]
99 Santen RJ, Lobenhofer EK, Afshari CA, Bao Y, Song RX. Adaptation of estrogen-regulated genes in long-term estradiol deprived MCF-7 breast cancer cells. Breast Cancer Res Treat 2005;94:213-23. [PMID: 16258703 DOI: 10.1007/s10549-005-5776-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
100 Czauderna F, Santel A, Hinz M, Fechtner M, Durieux B, Fisch G, Leenders F, Arnold W, Giese K, Klippel A, Kaufmann J. Inducible shRNA expression for application in a prostate cancer mouse model. Nucleic Acids Res 2003;31:e127. [PMID: 14576327 DOI: 10.1093/nar/gng127] [Cited by in Crossref: 123] [Cited by in F6Publishing: 116] [Article Influence: 6.8] [Reference Citation Analysis]
101 Weber W, Fussenegger M. Pharmacologic transgene control systems for gene therapy. J Gene Med 2006;8:535-56. [DOI: 10.1002/jgm.903] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
102 Arendt CW, Tang G, Zilberstein A. Vector Systems for the Delivery of Small Interfering RNAs: Managing the RISC. ChemBioChem 2003;4:1129-36. [DOI: 10.1002/cbic.200300695] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
103 Thakker DR, Natt F, Hüsken D, Maier R, Müller M, van der Putten H, Hoyer D, Cryan JF. Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc Natl Acad Sci U S A 2004;101:17270-5. [PMID: 15569935 DOI: 10.1073/pnas.0406214101] [Cited by in Crossref: 154] [Cited by in F6Publishing: 149] [Article Influence: 9.1] [Reference Citation Analysis]
104 Ngantung FA, Miller PG, Brushett FR, Tang GL, Wang DI. RNA interference of sialidase improves glycoprotein sialic acid content consistency. Biotechnol Bioeng 2006;95:106-19. [PMID: 16673415 DOI: 10.1002/bit.20997] [Cited by in Crossref: 73] [Cited by in F6Publishing: 56] [Article Influence: 4.9] [Reference Citation Analysis]
105 Seo JH, Jeong ES, Choi YK. Therapeutic effects of lentivirus-mediated shRNA targeting of cyclin D1 in human gastric cancer. BMC Cancer 2014;14:175. [PMID: 24618206 DOI: 10.1186/1471-2407-14-175] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
106 Zenke K, Kim KH. Novel fugu U6 promoter driven shRNA expression vector for efficient vector based RNAi in fish cell lines. Biochemical and Biophysical Research Communications 2008;371:480-3. [DOI: 10.1016/j.bbrc.2008.04.116] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
107 Weber W, Fussenegger M. Approaches for trigger-inducible viral transgene regulation in gene-based tissue engineering. Current Opinion in Biotechnology 2004;15:383-91. [DOI: 10.1016/j.copbio.2004.07.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
108 Sharma A, Tandon M, Bangari DS, Mittal SK. Adenoviral vector-based strategies for cancer therapy. Curr Drug ther 2009;4:117-38. [PMID: 20160875 DOI: 10.2174/157488509788185123] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
109 Nakamura K, Abu Lila AS, Matsunaga M, Doi Y, Ishida T, Kiwada H. A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA. Mol Ther 2011;19:2040-7. [PMID: 21878904 DOI: 10.1038/mt.2011.174] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
110 Otaki M, Sada K, Kadoya H, Nagano-Fujii M, Hotta H. Inhibition of measles virus and subacute sclerosing panencephalitis virus by RNA interference. Antiviral Res 2006;70:105-11. [PMID: 16530274 DOI: 10.1016/j.antiviral.2006.01.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
111 McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I, Gilmore BL, Burstein H, Peluso RW, Polisky B, Carter BJ, Davidson BL. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci U S A 2008;105:5868-73. [PMID: 18398004 DOI: 10.1073/pnas.0801775105] [Cited by in Crossref: 418] [Cited by in F6Publishing: 375] [Article Influence: 32.2] [Reference Citation Analysis]
112 Nielsen TT, Nielsen JE. Antisense gene silencing: therapy for neurodegenerative disorders? Genes (Basel) 2013;4:457-84. [PMID: 24705213 DOI: 10.3390/genes4030457] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
113 Yoshinouchi M, Yamada T, Kizaki M, Fen J, Koseki T, Ikeda Y, Nishihara T, Yamato K. In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. Mol Ther 2003;8:762-8. [PMID: 14599809 DOI: 10.1016/j.ymthe.2003.08.004] [Cited by in Crossref: 127] [Cited by in F6Publishing: 106] [Article Influence: 7.5] [Reference Citation Analysis]
114 Hilleman MR. Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc Natl Acad Sci U S A 2004;101 Suppl 2:14560-6. [PMID: 15297608 DOI: 10.1073/pnas.0404758101] [Cited by in F6Publishing: 86] [Reference Citation Analysis]
115 Salahpour A, Medvedev IO, Beaulieu JM, Gainetdinov RR, Caron MG. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals. Biol Psychiatry 2007;61:65-9. [PMID: 16712807 DOI: 10.1016/j.biopsych.2006.03.020] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
116 Grünweller A, Wyszko E, Bieber B, Jahnel R, Erdmann VA, Kurreck J. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res 2003;31:3185-93. [PMID: 12799446 DOI: 10.1093/nar/gkg409] [Cited by in Crossref: 198] [Cited by in F6Publishing: 188] [Article Influence: 11.0] [Reference Citation Analysis]
117 Otaki M, Jiang D, Sasayama M, Nagano-fujii M, Hotta H. Generation of Recombinant Adenovirus Expressing siRNA against the L mRNA of Measles Virus and Subacute Sclerosing Panencephalitis Virus. Microbiology and Immunology 2007;51:985-91. [DOI: 10.1111/j.1348-0421.2007.tb03995.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
118 Rozema DB, Lewis DL. siRNA delivery technologies for mammalian systems. TARGETS 2003;2:253-60. [DOI: 10.1016/s1477-3627(03)02381-x] [Cited by in Crossref: 19] [Article Influence: 1.1] [Reference Citation Analysis]
119 Zhang Z, Min W, Jevnikar AM. Use of RNA interference to minimize ischemia reperfusion injury. Transplantation Reviews 2012;26:140-55. [DOI: 10.1016/j.trre.2011.03.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
120 Ge Q, Dallas A, Ilves H, Shorenstein J, Behlke MA, Johnston BH. Effects of chemical modification on the potency, serum stability, and immunostimulatory properties of short shRNAs. RNA 2010;16:118-30. [PMID: 19948766 DOI: 10.1261/rna.1901810] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
121 Kargiotis O, Chetty C, Gondi CS, Tsung AJ, Dinh DH, Gujrati M, Lakka SS, Kyritsis AP, Rao JS. Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma. Oncogene. 2008;27:4830-4840. [PMID: 18438431 DOI: 10.1038/onc.2008.122] [Cited by in Crossref: 89] [Cited by in F6Publishing: 79] [Article Influence: 6.8] [Reference Citation Analysis]
122 Kasim V, Miyagishi M, Taira K. Control of siRNA expression using the Cre-loxP recombination system. Nucleic Acids Res 2004;32:e66. [PMID: 15107481 DOI: 10.1093/nar/gnh061] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
123 Shen Z, Shen T, Wientjes MG, O'Donnell MA, Au JL. Intravesical treatments of bladder cancer: review. Pharm Res 2008;25:1500-10. [PMID: 18369709 DOI: 10.1007/s11095-008-9566-7] [Cited by in Crossref: 112] [Cited by in F6Publishing: 86] [Article Influence: 8.6] [Reference Citation Analysis]
124 Boden D, Pusch O, Lee F, Tucker L, Shank PR, Ramratnam B. Promoter choice affects the potency of HIV-1 specific RNA interference. Nucleic Acids Res 2003;31:5033-8. [PMID: 12930953 DOI: 10.1093/nar/gkg704] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 4.2] [Reference Citation Analysis]
125 Hokaiwado N, Takeshita F, Naiki-Ito A, Asamoto M, Ochiya T, Shirai T. Glutathione S-transferase Pi mediates proliferation of androgen-independent prostate cancer cells. Carcinogenesis 2008;29:1134-8. [PMID: 18413363 DOI: 10.1093/carcin/bgn097] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
126 Lewin AS, Glazer PM, Milstone LM. Gene therapy for autosomal dominant disorders of keratin. J Investig Dermatol Symp Proc 2005;10:47-61. [PMID: 16250209 DOI: 10.1111/j.1087-0024.2005.10207.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
127 Chen X, Fan S, Song E. Noncoding RNAs: New Players in Cancers. Adv Exp Med Biol 2016;927:1-47. [PMID: 27376730 DOI: 10.1007/978-981-10-1498-7_1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
128 Moffat J, Sabatini DM. Building mammalian signalling pathways with RNAi screens. Nat Rev Mol Cell Biol 2006;7:177-87. [PMID: 16496020 DOI: 10.1038/nrm1860] [Cited by in Crossref: 151] [Cited by in F6Publishing: 114] [Article Influence: 10.1] [Reference Citation Analysis]
129 Paul CP. Subcellular Distribution of Small Interfering RNA: Directed Delivery Through RNA Polymerase III Expression Cassettes and Localization by In Situ Hybridization. RNA Interference. Elsevier; 2005. pp. 125-45. [DOI: 10.1016/s0076-6879(04)92008-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
130 Landen CN, Kinch MS, Sood AK. EphA2 as a target for ovarian cancer therapy. Expert Opin Ther Targets 2005;9:1179-87. [PMID: 16300469 DOI: 10.1517/14728222.9.6.1179] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
131 Hommel JD, Sears RM, Georgescu D, Simmons DL, DiLeone RJ. Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med. 2003;9:1539-1544. [PMID: 14634645 DOI: 10.1038/nm964] [Cited by in Crossref: 261] [Cited by in F6Publishing: 232] [Article Influence: 14.5] [Reference Citation Analysis]
132 Wang C, Chen L, Huang Y, Li K, Jinye A, Fan T, Zhao R, Xia X, Shen B, Du J, Liu Y. Exosome-delivered TRPP2 siRNA inhibits the epithelial-mesenchymal transition of FaDu cells. Oncol Lett 2019;17:1953-61. [PMID: 30675260 DOI: 10.3892/ol.2018.9752] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
133 Paranjpe S, Bowen WC, Bell AW, Nejak-bowen K, Luo J, Michalopoulos GK. Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference. Hepatology 2007;45:1471-7. [DOI: 10.1002/hep.21570] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 5.1] [Reference Citation Analysis]
134 Lee NS, Rossi JJ. Control of HIV-1 replication by RNA interference. Virus Res. 2004;102:53-58. [PMID: 15068880 DOI: 10.1016/j.virusres.2004.01.015] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 2.8] [Reference Citation Analysis]
135 Bennasser Y, Le SY, Benkirane M, Jeang KT. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005;22:607-19. [PMID: 15894278 DOI: 10.1016/j.immuni.2005.03.010] [Cited by in Crossref: 315] [Cited by in F6Publishing: 305] [Article Influence: 19.7] [Reference Citation Analysis]
136 Dierssen M, Ortiz-abalia J, Arqué G, de Lagrán MM, Fillat C. Pitfalls And Hopes in Down Syndrome Therapeutic Approaches: In the Search for Evidence-Based Treatments. Behav Genet 2006;36:454-68. [DOI: 10.1007/s10519-006-9050-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
137 Shen C, Buck AK, Liu X, Winkler M, Reske SN. Gene silencing by adenovirus-delivered siRNA. FEBS Letters 2003;539:111-4. [DOI: 10.1016/s0014-5793(03)00209-6] [Cited by in Crossref: 147] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
138 Gupta PK, Sonwane AA, Singh NK, Meshram CD, Dahiya SS, Pawar SS, Gupta SP, Chaturvedi VK, Saini M. Intracerebral delivery of small interfering RNAs (siRNAs) using adenoviral vector protects mice against lethal peripheral rabies challenge. Virus Res 2012;163:11-8. [PMID: 21864591 DOI: 10.1016/j.virusres.2011.08.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
139 Scherr M, Battmer K, Dallmann I, Ganser A, Eder M. Inhibition of GM-CSF receptor function by stable RNA interference in a NOD/SCID mouse hematopoietic stem cell transplantation model. Oligonucleotides 2003;13:353-63. [PMID: 15000826 DOI: 10.1089/154545703322617032] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
140 Heidenreich M, Zhang F. Applications of CRISPR-Cas systems in neuroscience. Nat Rev Neurosci. 2016;17:36-44. [PMID: 26656253 DOI: 10.1038/nrn.2015.2] [Cited by in Crossref: 159] [Cited by in F6Publishing: 113] [Article Influence: 26.5] [Reference Citation Analysis]
141 Zheng R, Xiong Q, Zuo B, Jiang S, Li F, Lei M, Deng C, Xiong Y. Using RNA interference to identify the different roles of SMAD2 and SMAD3 in NIH/3T3 fibroblast cells. Cell Biochem Funct 2008;26:548-56. [PMID: 18506886 DOI: 10.1002/cbf.1464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
142 Kim T, Singh RK, Kang MS, Kim J, Kim H. Inhibition of osteoclastogenesis through siRNA delivery with tunable mesoporous bioactive nanocarriers. Acta Biomaterialia 2016;29:352-64. [DOI: 10.1016/j.actbio.2015.09.035] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
143 Caplen NJ, Mousses S. Short interfering RNA (siRNA)-mediated RNA interference (RNAi) in human cells. Ann N Y Acad Sci 2003;1002:56-62. [PMID: 14751822 DOI: 10.1196/annals.1281.007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
144 Seth A, Oh DB, Lim YT. Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine. Nanomedicine (Lond) 2015;10:959-75. [PMID: 25867860 DOI: 10.2217/nnm.14.200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
145 Dillin A. The specifics of small interfering RNA specificity. Proc Natl Acad Sci U S A 2003;100:6289-91. [PMID: 12754379 DOI: 10.1073/pnas.1232238100] [Cited by in Crossref: 56] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
146 Lieberman J, Song E, Lee SK, Shankar P. Interfering with disease: opportunities and roadblocks to harnessing RNA interference. Trends Mol Med 2003;9:397-403. [PMID: 13129706 DOI: 10.1016/s1471-4914(03)00143-6] [Cited by in Crossref: 72] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
147 Brachtlova T, van Beusechem VW. Unleashing the Full Potential of Oncolytic Adenoviruses against Cancer by Applying RNA Interference: The Force Awakens. Cells 2018;7:E228. [PMID: 30477117 DOI: 10.3390/cells7120228] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
148 Morral N, Witting SR. shRNA-induced interferon-stimulated gene analysis. Methods Mol Biol 2012;820:163-77. [PMID: 22131031 DOI: 10.1007/978-1-61779-439-1_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
149 Wang XL, Xu R, Wu X, Gillespie D, Jensen R, Lu ZR. Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice. Mol Pharm 2009;6:738-46. [PMID: 19296675 DOI: 10.1021/mp800192d] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 8.1] [Reference Citation Analysis]
150 Ichim TE, Li M, Qian H, Popov IA, Rycerz K, Zheng X, White D, Zhong R, Min WP. RNA interference: a potent tool for gene-specific therapeutics. Am J Transplant 2004;4:1227-36. [PMID: 15268723 DOI: 10.1111/j.1600-6143.2004.00530.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 4.0] [Reference Citation Analysis]
151 Mckimmie CS, Singh MD, Hewit K, Lopez-franco O, Le Brocq M, Rose-john S, Lee KM, Baker AH, Wheat R, Blackbourn DJ, Nibbs RJB, Graham GJ. An analysis of the function and expression of D6 on lymphatic endothelial cells. Blood 2013;121:3768-77. [DOI: 10.1182/blood-2012-04-425314] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 6.8] [Reference Citation Analysis]
152 tenOever BR. RNA viruses and the host microRNA machinery. Nat Rev Microbiol. 2013;11:169-180. [PMID: 23411862 DOI: 10.1038/nrmicro2971] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 12.0] [Reference Citation Analysis]
153 Fabioux C, Corporeau C, Quillien V, Favrel P, Huvet A. In vivo RNA interference in oyster--vasa silencing inhibits germ cell development. FEBS J 2009;276:2566-73. [PMID: 19476495 DOI: 10.1111/j.1742-4658.2009.06982.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 61] [Article Influence: 6.7] [Reference Citation Analysis]
154 Xue C, Hu S, Gao ZH, Wang L, Luo MX, Yu X, Li BF, Shen Z, Wu ZS. Programmably tiling rigidified DNA brick on gold nanoparticle as multi-functional shell for cancer-targeted delivery of siRNAs. Nat Commun 2021;12:2928. [PMID: 34006888 DOI: 10.1038/s41467-021-23250-5] [Reference Citation Analysis]
155 Weber W, Malphettes L, de Jesus M, Schoenmakers R, El-Baba MD, Spielmann M, Keller B, Weber CC, van de Wetering P, Aubel D, Wurm FM, Fussenegger M. Engineered Streptomyces quorum-sensing components enable inducible siRNA-mediated translation control in mammalian cells and adjustable transcription control in mice. J Gene Med 2005;7:518-25. [PMID: 15521094 DOI: 10.1002/jgm.682] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
156 Trülzsch B, Wood M. Applications of nucleic acid technology in the CNS: Applications of nucleic acid technology in the CNS. Journal of Neurochemistry 2004;88:257-65. [DOI: 10.1111/j.1471-4159.2004.02153.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
157 Crook MF, Akyürek LM. Gene Transfer Strategies to Inhibit Neointima Formation. Trends in Cardiovascular Medicine 2003;13:102-6. [DOI: 10.1016/s1050-1738(02)00255-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
158 Spänkuch B, Matthess Y, Knecht R, Zimmer B, Kaufmann M, Strebhardt K. Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1. J Natl Cancer Inst 2004;96:862-72. [PMID: 15173270 DOI: 10.1093/jnci/djh146] [Cited by in Crossref: 91] [Cited by in F6Publishing: 81] [Article Influence: 5.4] [Reference Citation Analysis]
159 Genc S, Koroglu TF, Genc K. RNA interference in neuroscience. Brain Res Mol Brain Res 2004;132:260-70. [PMID: 15582163 DOI: 10.1016/j.molbrainres.2004.02.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
160 Forte A, Napolitano MA, Cipollaro M, Giordano A, Cascino A, Galderisi U. An effective method for adenoviral-mediated delivery of small interfering RNA into mesenchymal stem cells. J Cell Biochem 2007;100:293-302. [DOI: 10.1002/jcb.21025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
161 Grimm D, Kay MA. Therapeutic short hairpin RNA expression in the liver: viral targets and vectors. Gene Ther 2006;13:563-75. [PMID: 16453009 DOI: 10.1038/sj.gt.3302727] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 4.0] [Reference Citation Analysis]
162 Farazmandfar T, Haghshenas MR, Shahbazi M. Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells. Hum Gene Ther 2015;26:680-7. [PMID: 26077977 DOI: 10.1089/hum.2015.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
163 Ying SY, Lin SL. Intron-mediated RNA interference and microRNA biogenesis. Methods Mol Biol 2009;487:387-413. [PMID: 19301658 DOI: 10.1007/978-1-60327-547-7_19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.3] [Reference Citation Analysis]
164 Lambeth LS, Smith CA. Short Hairpin RNA-Mediated Gene Silencing. In: Taxman DJ, editor. siRNA Design. Totowa: Humana Press; 2013. pp. 205-32. [DOI: 10.1007/978-1-62703-119-6_12] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
165 Lundstrom K. Latest development in viral vectors for gene therapy. Trends Biotechnol. 2003;21:117-122. [PMID: 12628368 DOI: 10.1016/s0167-7799(02)00042-2] [Cited by in Crossref: 146] [Cited by in F6Publishing: 40] [Article Influence: 8.1] [Reference Citation Analysis]
166 Shapiro OH, Kramarsky-Winter E, Gavish AR, Stocker R, Vardi A. A coral-on-a-chip microfluidic platform enabling live-imaging microscopy of reef-building corals. Nat Commun 2016;7:10860. [PMID: 26940983 DOI: 10.1038/ncomms10860] [Cited by in Crossref: 50] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
167 Gros R, Ding Q, Chorazyczewski J, Pickering JG, Limbird LE, Feldman RD. Adenylyl cyclase isoform-selective regulation of vascular smooth muscle proliferation and cytoskeletal reorganization. Circ Res 2006;99:845-52. [PMID: 16973907 DOI: 10.1161/01.RES.0000245189.21703.c0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
168 Mccaffrey AP, Kay MA. RNA interference gene therapy: RNA interference gets infectious. Gene Ther 2003;10:1205-1205. [DOI: 10.1038/sj.gt.3302035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
169 Mishra G, Chadha P, Chaudhury I, Das RH. Inhibition of Autographa californica nucleopolyhedrovirus (AcNPV) polyhedrin gene expression by DNAzyme knockout of its serine/threonine kinase (pk1) gene. Virus Research 2008;135:197-201. [DOI: 10.1016/j.virusres.2008.02.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
170 Pei DS, Di JH, Chen FF, Zheng JN. Oncolytic-adenovirus-expressed RNA interference for cancer therapy. Expert Opin Biol Ther 2010;10:1331-41. [PMID: 20684738 DOI: 10.1517/14712598.2010.512002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
171 Yang Y, Zhong S, Wang K, Huang J. Gold nanoparticle based fluorescent oligonucleotide probes for imaging and therapy in living systems. Analyst 2019;144:1052-72. [DOI: 10.1039/c8an02070a] [Cited by in Crossref: 22] [Cited by in F6Publishing: 1] [Article Influence: 11.0] [Reference Citation Analysis]
172 Déglon N, Hantraye P. Viral vectors as tools to model and treat neurodegenerative disorders. J Gene Med 2005;7:530-9. [PMID: 15651039 DOI: 10.1002/jgm.707] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
173 Pushparaj PN, Melendez AJ. Short interfering RNA (siRNA) as a novel therapeutic. Clin Exp Pharmacol Physiol. 2006;33:504-510. [PMID: 16700886 DOI: 10.1111/j.1440-1681.2006.04399.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
174 Guzman-Villanueva D, El-Sherbiny IM, Herrera-Ruiz D, Vlassov AV, Smyth HD. Formulation approaches to short interfering RNA and MicroRNA: challenges and implications. J Pharm Sci 2012;101:4046-66. [PMID: 22927140 DOI: 10.1002/jps.23300] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
175 Gou D, Narasaraju T, Chintagari NR, Jin N, Wang P, Liu L. Gene silencing in alveolar type II cells using cell-specific promoter in vitro and in vivo. Nucleic Acids Res 2004;32:e134. [PMID: 15452203 DOI: 10.1093/nar/gnh129] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
176 Peng Y, Lu J, Shen X. shRNA driven by Pol II/T7 dual-promoter system effectively induce cell-specific RNA interference in mammalian cells. Biochemical and Biophysical Research Communications 2007;360:496-500. [DOI: 10.1016/j.bbrc.2007.06.100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
177 Ferrari M. Vectoring siRNA therapeutics into the clinic. Nat Rev Clin Oncol 2010;7:485-6. [DOI: 10.1038/nrclinonc.2010.131] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
178 Hino T, Yokota T, Ito S, Nishina K, Kang Y, Mori S, Hori S, Kanda T, Terasaki T, Mizusawa H. In vivo delivery of small interfering RNA targeting brain capillary endothelial cells. Biochemical and Biophysical Research Communications 2006;340:263-7. [DOI: 10.1016/j.bbrc.2005.11.173] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
179 Hosono T, Mizuguchi H, Katayama K, Xu ZL, Sakurai F, Ishii-Watabe A, Kawabata K, Yamaguchi T, Nakagawa S, Mayumi T. Adenovirus vector-mediated doxycycline-inducible RNA interference. Hum Gene Ther. 2004;15:813-819. [PMID: 15319038 DOI: 10.1089/1043034041648462] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
180 Raoul C, Barker SD, Aebischer P. Viral-based modelling and correction of neurodegenerative diseases by RNA interference. Gene Ther 2006;13:487-95. [DOI: 10.1038/sj.gt.3302690] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
181 Haupenthal J, Baehr C, Kiermayer S, Zeuzem S, Piiper A. Inhibition of RNAse A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum. Biochem Pharmacol 2006;71:702-10. [PMID: 16376306 DOI: 10.1016/j.bcp.2005.11.015] [Cited by in Crossref: 105] [Cited by in F6Publishing: 93] [Article Influence: 7.0] [Reference Citation Analysis]
182 Sumimoto H, Kawakami Y. Lentiviral vector-mediated RNAi and its use for cancer research. Future Oncol. 2007;3:655-664. [PMID: 18714168 DOI: 10.2217/14796694.3.6.655] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
183 Arrighi JF, Pion M, Wiznerowicz M, Geijtenbeek TB, Garcia E, Abraham S, Leuba F, Dutoit V, Ducrey-Rundquist O, van Kooyk Y. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J Virol. 2004;78:10848-10855. [PMID: 15452205 DOI: 10.1128/JVI.78.20.10848-10855.2004] [Cited by in Crossref: 89] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
184 Zhang H, Jiang H, Wang W, Gong J, Zhang L, Chen Z, Ding Q. Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth. Urol Oncol 2012;30:920-7. [PMID: 21478038 DOI: 10.1016/j.urolonc.2010.10.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
185 Musatov S, Chen W, Pfaff DW, Kaplitt MG, Ogawa S. RNAi-mediated silencing of estrogen receptor {alpha} in the ventromedial nucleus of hypothalamus abolishes female sexual behaviors. Proc Natl Acad Sci U S A 2006;103:10456-60. [PMID: 16803960 DOI: 10.1073/pnas.0603045103] [Cited by in Crossref: 158] [Cited by in F6Publishing: 133] [Article Influence: 10.5] [Reference Citation Analysis]
186 Karki A, Giddings E, Carreras A, Champagne D, Fortner K, Rincon M, Wu J. Sonoporation as an Approach for siRNA delivery into T cells. Ultrasound Med Biol 2019;45:3222-31. [PMID: 31540758 DOI: 10.1016/j.ultrasmedbio.2019.06.406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
187 Jana S, Chakraborty C, Nandi S, Deb JK. RNA interference: potential therapeutic targets. Appl Microbiol Biotechnol. 2004;65:649-657. [PMID: 15372214 DOI: 10.1007/s00253-004-1732-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
188 Suzuki H, Matsumoto N, Suzuki T, Chang MO, Takaku H. Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy. Virol J 2009;6:156. [PMID: 19796392 DOI: 10.1186/1743-422X-6-156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
189 Hurtado Picó A, Wang X, Sipo I, Siemetzki U, Eberle J, Poller W, Fechner H. Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenoviruses. Mol Ther. 2005;11:563-577. [PMID: 15771959 DOI: 10.1016/j.ymthe.2004.10.021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
190 Kohan DE. Progress in gene targeting: using mutant mice to study renal function and disease. Kidney Int 2008;74:427-37. [PMID: 18418351 DOI: 10.1038/ki.2008.146] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
191 Wang QC, Nie QH, Feng ZH. RNA interference: antiviral wea-pon and beyond. World J Gastroenterol. 2003;9:1657-1661. [PMID: 12918096 DOI: 10.3748/wjg.v9.i8.1657] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
192 Yin L, Song Z, Qu Q, Kim KH, Zheng N, Yao C, Chaudhury I, Tang H, Gabrielson NP, Uckun FM, Cheng J. Supramolecular Self-Assembled Nanoparticles Mediate Oral Delivery of Therapeutic TNF-α siRNA against Systemic Inflammation. Angew Chem 2013;125:5869-73. [DOI: 10.1002/ange.201209991] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
193 Deshayes S, Simeoni F, Morris MC, Divita G, Heitz F. Peptide-mediated delivery of nucleic acids into mammalian cells. Methods Mol Biol 2007;386:299-308. [PMID: 18604951 DOI: 10.1007/978-1-59745-430-8_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
194 Liang M, Kamata M, Chen KN, Pariente N, An DS, Chen IS. Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction. J Gene Med 2010;12:255-65. [PMID: 20186995 DOI: 10.1002/jgm.1440] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
195 Niu XY, Peng ZL, Duan WQ, Wang H, Wang P. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. Int J Gynecol Cancer 2006;16:743-51. [PMID: 16681755 DOI: 10.1111/j.1525-1438.2006.00384.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 4.8] [Reference Citation Analysis]
196 Kato Y, Taira K. Expression of siRNA from a Single Transcript That Includes Multiple Ribozymes in Mammalian Cells. Oligonucleotides 2003;13:335-43. [DOI: 10.1089/154545703322617014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
197 Klootwijk RD, Savelkoul PJ, Ciccone C, Manoli I, Caplen NJ, Krasnewich DM, Gahl WA, Huizing M. Allele-specific silencing of the dominant disease allele in sialuria by RNA interference. FASEB J 2008;22:3846-52. [PMID: 18653764 DOI: 10.1096/fj.08-110890] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
198 Wang Q, Carmichael GG. Effects of length and location on the cellular response to double-stranded RNA. Microbiol Mol Biol Rev 2004;68:432-52, table of contents. [PMID: 15353564 DOI: 10.1128/MMBR.68.3.432-452.2004] [Cited by in Crossref: 81] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
199 Wu W, Hodges E, Redelius J, Höög C. A novel approach for evaluating the efficiency of siRNAs on protein levels in cultured cells. Nucleic Acids Res 2004;32:e17. [PMID: 14739231 DOI: 10.1093/nar/gnh010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
200 Chen X, Liu Y, Wen Y, Yu Q, Liu J, Zhao Y, Liu J, Ye G. A photothermal-triggered nitric oxide nanogenerator combined with siRNA for precise therapy of osteoarthritis by suppressing macrophage inflammation. Nanoscale 2019;11:6693-709. [PMID: 30900717 DOI: 10.1039/c8nr10013f] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 10.5] [Reference Citation Analysis]
201 Furalyov VA, Kravchenko IV, Khotchenkov VP, Popov VO. siRNAs targeting mouse myostatin. Biochemistry (Mosc) 2008;73:342-5. [PMID: 18393772 DOI: 10.1134/s0006297908030164] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
202 Weber W, Fussenegger M. Novel Gene Switches. In: Feil R, Metzger D, editors. Conditional Mutagenesis: An Approach to Disease Models. Berlin: Springer Berlin Heidelberg; 2007. pp. 73-105. [DOI: 10.1007/978-3-540-35109-2_4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
203 Van den Haute C, Eggermont K, Nuttin B, Debyser Z, Baekelandt V. Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain. Hum Gene Ther. 2003;14:1799-1807. [PMID: 14670130 DOI: 10.1089/104303403322611809] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 4.5] [Reference Citation Analysis]
204 Zhu S, Mc Henry KT, Lane WS, Fenteany G. A chemical inhibitor reveals the role of Raf kinase inhibitor protein in cell migration. Chem Biol. 2005;12:981-991. [PMID: 16183022 DOI: 10.1016/j.chembiol.2005.07.007] [Cited by in Crossref: 74] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
205 Sindhu A, Arora P, Chaudhury A. Illuminating the gateway of gene silencing: perspective of RNA interference technology in clinical therapeutics. Mol Biotechnol 2012;51:289-302. [PMID: 21947958 DOI: 10.1007/s12033-011-9456-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
206 Ralph G, Binley K, Wong L, Azzouz M, Mazarakis N. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors. Clinical Science 2006;110:37-46. [DOI: 10.1042/cs20050158] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
207 Malphettes L, Fussenegger M. Improved transgene expression fine-tuning in mammalian cells using a novel transcription–translation network. Journal of Biotechnology 2006;124:732-46. [DOI: 10.1016/j.jbiotec.2006.01.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
208 Gou D, Jin N, Liu L. Gene silencing in mammalian cells by PCR-based short hairpin RNA. FEBS Lett. 2003;548:113-118. [PMID: 12885417 DOI: 10.1016/s0014-5793(03)00630-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
209 Geley S, Müller C. RNAi: ancient mechanism with a promising future. Exp Gerontol 2004;39:985-98. [PMID: 15236758 DOI: 10.1016/j.exger.2004.03.040] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
210 Dash S, Haque S, Joshi V, Prabhu R, Hazari S, Fermin C, Garry R. HCV-hepatocellular carcinoma: new findings and hope for effective treatment. Microsc Res Tech 2005;68:130-48. [PMID: 16276514 DOI: 10.1002/jemt.20227] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
211 Yuan J, Wang X, Zhang Y, Hu X, Deng X, Fei J, Li N. shRNA transcribed by RNA Pol II promoter induce RNA interference in mammalian cell. Mol Biol Rep 2006;33:43-9. [PMID: 16636916 DOI: 10.1007/s11033-005-3965-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
212 Devroe E, Silver PA. Therapeutic potential of retroviral RNAi vectors. Expert Opinion on Biological Therapy 2005;4:319-27. [DOI: 10.1517/14712598.4.3.319] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
213 Manrique C, Compan V, Rosselet C, Duflo SG. Specific knock-down of GAD67 in the striatum using naked small interfering RNAs. J Biotechnol 2009;142:185-92. [PMID: 19497341 DOI: 10.1016/j.jbiotec.2009.05.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
214 Lee JS, Hmama Z, Mui A, Reiner NE. Stable gene silencing in human monocytic cell lines using lentiviral-delivered small interference RNA. Silencing of the p110alpha isoform of phosphoinositide 3-kinase reveals differential regulation of adherence induced by 1alpha,25-dihydroxycholecalciferol and bacterial lipopolysaccharide. J Biol Chem. 2004;279:9379-9388. [PMID: 14672955 DOI: 10.1074/jbc.m310638200] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
215 Mohamed HF. Molecular analysis and anticancer properties of two identified isolates, Fusarium solani and Emericella nidulans isolated from Wady El-Natron soil in Egypt against Caco-2 (ATCC) cell line. Asian Pac J Trop Biomed 2012;2:863-9. [PMID: 23569862 DOI: 10.1016/S2221-1691(12)60244-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
216 Sun H, Fu S, Cui S, Yin X, Sun X, Qi X, Cui K, Wang J, Ma L, Liu FY, Liao FF, Wang XH, Yi M, Wan Y. Development of a CRISPR-SaCas9 system for projection- and function-specific gene editing in the rat brain. Sci Adv 2020;6:eaay6687. [PMID: 32206715 DOI: 10.1126/sciadv.aay6687] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
217 Ruigrok MJR, Maggan N, Willaert D, Frijlink HW, Melgert BN, Olinga P, Hinrichs WLJ. siRNA-Mediated RNA Interference in Precision-Cut Tissue Slices Prepared from Mouse Lung and Kidney. AAPS J 2017;19:1855-63. [PMID: 28895093 DOI: 10.1208/s12248-017-0136-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
218 Laflamme M, Robichaud GA. Gene Suppression Technologies in High-Throughput Analysis: Front- and Back-side Applications. OMICS: A Journal of Integrative Biology 2007;11:129-42. [DOI: 10.1089/omi.2007.4321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
219 Xin H, Bernal A, Amato FA, Pinhasov A, Kauffman J, Brenneman DE, Derian CK, Andrade-gordon P, Plata-salamán CR, Ilyin SE. High-Throughput siRNA-Based Functional Target Validation. J Biomol Screen 2004;9:286-93. [DOI: 10.1177/1087057104263533] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
220 Lee JS, Oh E, Yoo JY, Choi KS, Yoon MJ, Yun CO. Adenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cells. Oncotarget 2015;6:4051-65. [PMID: 25726528 DOI: 10.18632/oncotarget.3018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
221 Maxwell MM, Pasinelli P, Kazantsev AG, Brown RH Jr. RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells. Proc Natl Acad Sci U S A 2004;101:3178-83. [PMID: 14981234 DOI: 10.1073/pnas.0308726100] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
222 Wang Z, Liu W, Fan C, Chen N. Visualizing mRNA in live mammalian cells. Methods 2019;161:16-23. [DOI: 10.1016/j.ymeth.2019.03.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
223 Thakker DR, Hoyer D, Cryan JF. Interfering with the brain: use of RNA interference for understanding the pathophysiology of psychiatric and neurological disorders. Pharmacol Ther 2006;109:413-38. [PMID: 16183135 DOI: 10.1016/j.pharmthera.2005.08.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
224 Honda M, Masui F, Kanzawa N, Tsuchiya T, Toyo-oka T. Specific knockdown of m-calpain blocks myogenesis with cDNA deduced from the corresponding RNAi. Am J Physiol Cell Physiol 2008;294:C957-65. [PMID: 18216163 DOI: 10.1152/ajpcell.00505.2007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
225 Milhavet O, Gary DS, Mattson MP. RNA Interference in Biology and Medicine. Pharmacol Rev 2003;55:629-48. [DOI: 10.1124/pr.55.4.1] [Cited by in Crossref: 83] [Cited by in F6Publishing: 71] [Article Influence: 4.6] [Reference Citation Analysis]
226 Shrivats AR, Mishina Y, Averick S, Matyjaszewski K, Hollinger JO. In Vivo GFP Knockdown by Cationic Nanogel-siRNA Polyplexes. Bioengineering (Basel) 2015;2:160-75. [PMID: 27280121 DOI: 10.3390/bioengineering2030160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
227 Moore F, Cunha DA, Mulder H, Eizirik DL. Use of RNA interference to investigate cytokine signal transduction in pancreatic beta cells. Methods Mol Biol 2012;820:179-94. [PMID: 22131032 DOI: 10.1007/978-1-61779-439-1_11] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
228 Liu R, Sun J, Zhang Z, Xu Y. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo. Cell Biol Int 2012;36:863-72. [PMID: 22612256 DOI: 10.1042/CBI20110662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
229 Arı́s A, Villaverde A. Engineering nuclear localization signals in modular protein vehicles for gene therapy. Biochemical and Biophysical Research Communications 2003;304:625-31. [DOI: 10.1016/s0006-291x(03)00644-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
230 Duan W, Wang T, Shigdar S, Tran P. RNA Aptamers-Guided Precision Cancer Medicine. In: Vo Van T, Nguyen Le TA, Nguyen Duc T, editors. 6th International Conference on the Development of Biomedical Engineering in Vietnam (BME6). Singapore: Springer; 2018. pp. 529-35. [DOI: 10.1007/978-981-10-4361-1_90] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
231 Arts GJ, Langemeijer E, Tissingh R, Ma L, Pavliska H, Dokic K, Dooijes R, Mesić E, Clasen R, Michiels F, van der Schueren J, Lambrecht M, Herman S, Brys R, Thys K, Hoffmann M, Tomme P, van Es H. Adenoviral vectors expressing siRNAs for discovery and validation of gene function. Genome Res 2003;13:2325-32. [PMID: 12975310 DOI: 10.1101/gr.1332603] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 4.3] [Reference Citation Analysis]
232 Li J, Chi Y, Wang C, Wu J, Yang H, Zhang D, Zhu Y, Wang N, Yang J, Guan Y. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway. Hepatology 2011;53:1906-16. [PMID: 21412813 DOI: 10.1002/hep.24295] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
233 Ji C, Yue S, Gu J, Kong Y, Chen H, Yu C, Sun Z, Zhao M. 2,7-Dibromocarbazole interferes with tube formation in HUVECs by altering Ang2 promoter DNA methylation status. Sci Total Environ 2019;697:134156. [PMID: 32380619 DOI: 10.1016/j.scitotenv.2019.134156] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
234 Tigges M, Dénervaud N, Greber D, Stelling J, Fussenegger M. A synthetic low-frequency mammalian oscillator. Nucleic Acids Res 2010;38:2702-11. [PMID: 20197318 DOI: 10.1093/nar/gkq121] [Cited by in Crossref: 71] [Cited by in F6Publishing: 51] [Article Influence: 6.5] [Reference Citation Analysis]
235 Xiong G, Chen X, Zhang Q, Fang Y, Chen W, Li C, Zhang J. RNA interference influenced the proliferation and invasion of XWLC-05 lung cancer cells through inhibiting aquaporin 3. Biochem Biophys Res Commun 2017;485:627-34. [PMID: 28189680 DOI: 10.1016/j.bbrc.2017.02.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
236 Sigmund CD, Davisson RL. Targeting Brain AT 1 Receptors By RNA Interference. Hypertension 2006;47:145-6. [DOI: 10.1161/01.hyp.0000200278.64801.4e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
237 Dorsett Y, Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov. 2004;3:318-329. [PMID: 15060527 DOI: 10.1038/nrd1345] [Cited by in Crossref: 643] [Cited by in F6Publishing: 572] [Article Influence: 37.8] [Reference Citation Analysis]
238 Lien YH, Lai L. Gene therapy for renal disorders. Expert Opinion on Biological Therapy 2005;4:919-26. [DOI: 10.1517/14712598.4.6.919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
239 Kovar H. Ewing tumor biology: perspectives for innovative treatment approaches. Adv Exp Med Biol 2003;532:27-37. [PMID: 12908547 DOI: 10.1007/978-1-4615-0081-0_4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
240 Jacobs AH, Winkler A, Castro MG, Lowenstein P. Human gene therapy and imaging in neurological diseases. Eur J Nucl Med Mol Imaging. 2005;32 Suppl 2:S358-S383. [PMID: 16328505 DOI: 10.1007/s00259-005-1960-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
241 Minakuchi Y, Takeshita F, Kosaka N, Sasaki H, Yamamoto Y, Kouno M, Honma K, Nagahara S, Hanai K, Sano A. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res. 2004;32:e109. [PMID: 15272050 DOI: 10.1093/nar/gnh093] [Cited by in Crossref: 257] [Cited by in F6Publishing: 219] [Article Influence: 15.1] [Reference Citation Analysis]
242 Liu R, Hsieh CY, Lam KS. New approaches in identifying drugs to inactivate oncogene products. Semin Cancer Biol 2004;14:13-21. [PMID: 14757532 DOI: 10.1016/j.semcancer.2003.11.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
243 Schiffelers RM, van Kolfschoten SC, van Dijk M, Scaria PV, Woodle MC, Storm G. siRNA as a new drug: intellectual property. Expert Opinion on Therapeutic Patents 2005;15:141-52. [DOI: 10.1517/13543776.15.2.141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
244 Jiang Y, Zhao Y, He F, Wang H. Artificial MicroRNA-Mediated Tgfbr2 and Pdgfrb Co-Silencing Ameliorates Carbon Tetrachloride-Induced Hepatic Fibrosis in Mice. Hum Gene Ther 2019;30:179-96. [PMID: 30024280 DOI: 10.1089/hum.2018.047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
245 Li L, Lin X, Khvorova A, Fesik SW, Shen Y. Defining the optimal parameters for hairpin-based knockdown constructs. RNA 2007;13:1765-74. [PMID: 17698642 DOI: 10.1261/rna.599107] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 4.9] [Reference Citation Analysis]
246 Xia XG, Zhou H, Xu Z. Promises and challenges in developing RNAi as a research tool and therapy for neurodegenerative diseases. Neurodegener Dis 2005;2:220-31. [PMID: 16909029 DOI: 10.1159/000089629] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
247 Piao L, Li H, Teng L, Yung BC, Sugimoto Y, Brueggemeier RW, Lee RJ. Human serum albumin-coated lipid nanoparticles for delivery of siRNA to breast cancer. Nanomedicine. 2013;9:122-129. [PMID: 22542825 DOI: 10.1016/j.nano.2012.03.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
248 Hassani Z, François JC, Alfama G, Dubois GM, Paris M, Giovannangeli C, Demeneix BA. A hybrid CMV-H1 construct improves efficiency of PEI-delivered shRNA in the mouse brain. Nucleic Acids Res 2007;35:e65. [PMID: 17426128 DOI: 10.1093/nar/gkm152] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
249 Sliva K, Schnierle BS. Selective gene silencing by viral delivery of short hairpin RNA. Virol J 2010;7:248. [PMID: 20858246 DOI: 10.1186/1743-422X-7-248] [Cited by in Crossref: 66] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
250 Matsui Y, Kobayashi N, Nishikawa M, Takakura Y. Sequence-specific suppression of mdr1a/1b expression in mice via RNA interference. Pharm Res. 2005;22:2091-2098. [PMID: 16184445 DOI: 10.1007/s11095-005-8178-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
251 Sun A, Tang J, Terranova PF, Zhang X, Thrasher JB, Li B. Adeno-associated virus-delivered short hairpin-structured RNA for androgen receptor gene silencing induces tumor eradication of prostate cancer xenografts in nude mice: a preclinical study. Int J Cancer 2010;126:764-74. [PMID: 19642108 DOI: 10.1002/ijc.24778] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
252 Yoshinari K, Miyagishi M, Taira K. Effects on RNAi of the tight structure, sequence and position of the targeted region. Nucleic Acids Res. 2004;32:691-699. [PMID: 14762201 DOI: 10.1093/nar/gkh221] [Cited by in Crossref: 103] [Cited by in F6Publishing: 89] [Article Influence: 6.1] [Reference Citation Analysis]
253 Gould RA, Aboulmouna LM, Varner JD, Butcher JT. Hierarchical approaches for systems modeling in cardiac development. Wiley Interdiscip Rev Syst Biol Med 2013;5:289-305. [PMID: 23463736 DOI: 10.1002/wsbm.1217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
254 Watson LM, Wood MJ. RNA therapy for polyglutamine neurodegenerative diseases. Expert Rev Mol Med 2012;14:e3. [PMID: 22293529 DOI: 10.1017/erm.2011.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
255 Zhang H, Shykind B, Sun T. Approaches to manipulating microRNAs in neurogenesis. Front Neurosci 2012;6:196. [PMID: 23335878 DOI: 10.3389/fnins.2012.00196] [Cited by in Crossref: 15] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
256 Scherr M, Battmer K, Schultheis B, Ganser A, Eder M. Stable RNA interference (RNAi) as an option for anti-bcr-abl therapy. Gene Ther 2005;12:12-21. [DOI: 10.1038/sj.gt.3302328] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
257 Lau TS, Li Y, Kameoka M, Ng TB, Wan DCC. Suppression of HIV replication using RNA interference against HIV-1 integrase. FEBS Letters 2007;581:3253-9. [DOI: 10.1016/j.febslet.2007.06.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
258 Giering JC, Grimm D, Storm TA, Kay MA. Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic. Mol Ther. 2008;16:1630-1636. [PMID: 18665161 DOI: 10.1038/mt.2008.144] [Cited by in Crossref: 149] [Cited by in F6Publishing: 129] [Article Influence: 11.5] [Reference Citation Analysis]
259 Zhou X, Cheng S, Zhao C, Lin C, Wang D, Zhao Y. Expression and functional analysis of the Akt gene from Daphnia pulex. Comp Biochem Physiol B Biochem Mol Biol 2020;248-249:110462. [PMID: 32540280 DOI: 10.1016/j.cbpb.2020.110462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
260 Gherardini L, Bardi G, Gennaro M, Pizzorusso T. Novel siRNA delivery strategy: a new "strand" in CNS translational medicine? Cell Mol Life Sci 2014;71:1-20. [PMID: 23508806 DOI: 10.1007/s00018-013-1310-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
261 Zou SW, Ai KX, Wang ZG, Yuan Z, Yan J, Zheng Q. The role of Med19 in the proliferation and tumorigenesis of human hepatocellular carcinoma cells. Acta Pharmacol Sin 2011;32:354-60. [PMID: 21372827 DOI: 10.1038/aps.2010.223] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
262 Koopman P. Developmental biology: gender benders. Nature 2003;426:241. [PMID: 14628035 DOI: 10.1038/426241a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
263 Pfister EL, Kennington L, Straubhaar J, Wagh S, Liu W, DiFiglia M, Landwehrmeyer B, Vonsattel JP, Zamore PD, Aronin N. Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients. Curr Biol 2009;19:774-8. [PMID: 19361997 DOI: 10.1016/j.cub.2009.03.030] [Cited by in Crossref: 174] [Cited by in F6Publishing: 156] [Article Influence: 14.5] [Reference Citation Analysis]
264 Pietola L. Effects of p27 Kip1 - and p53- shRNAs on kanamycin damaged mouse cochlea. WJO 2012;2:1. [DOI: 10.5319/wjo.v2.i1.1] [Reference Citation Analysis]
265 Denovan-Wright EM, Davidson BL. RNAi: a potential therapy for the dominantly inherited nucleotide repeat diseases. Gene Ther 2006;13:525-31. [PMID: 16237462 DOI: 10.1038/sj.gt.3302664] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
266 Suzuki I, Im S, Tada A, Scott C, Akcali C, Davis MB, Barsh G, Hearing V, Abdel-Malek Z. Participation of the melanocortin-1 receptor in the UV control of pigmentation. J Investig Dermatol Symp Proc 1999;4:29-34. [PMID: 10537004 DOI: 10.1038/sj.jidsp.5640177] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
267 Liu CC, Cheng JT, Hung KC, Chia YY, Tan PH. Lentiviral vector-encoded microRNA-based shRNA-mediated gene knockdown of N-methyl-D-aspartate receptors in skin reduces pain. Brain Behav 2017;7:e00587. [PMID: 28127509 DOI: 10.1002/brb3.587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
268 Pinkenburg O, Platz J, Beisswenger C, Vogelmeier C, Bals R. Inhibition of NF-kappaB mediated inflammation by siRNA expressed by recombinant adeno-associated virus. J Virol Methods. 2004;120:119-122. [PMID: 15234817 DOI: 10.1016/j.jviromet.2004.04.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
269 Qin Z, Wang J, Gu Z. Development of novel therapies for Huntington's disease: hope and challenge1. Acta Pharmacologica Sinica 2005;26:129-42. [DOI: 10.1111/j.1745-7254.2005.00520.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
270 Kawakami Y, Ii M, Matsumoto T, Kawamoto A, Kuroda R, Akimaru H, Mifune Y, Shoji T, Fukui T, Asahi M, Kurosaka M, Asahara T. A small interfering RNA targeting Lnk accelerates bone fracture healing with early neovascularization. Lab Invest 2013;93:1036-53. [PMID: 23897412 DOI: 10.1038/labinvest.2013.93] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
271 Miller VM, Xia H, Marrs GL, Gouvion CM, Lee G, Davidson BL, Paulson HL. Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci USA. 2003;100:7195-7200. [PMID: 12782788 DOI: 10.1073/pnas.1231012100] [Cited by in Crossref: 285] [Cited by in F6Publishing: 238] [Article Influence: 15.8] [Reference Citation Analysis]
272 Amar L, Desclaux M, Faucon-Biguet N, Mallet J, Vogel R. Control of small inhibitory RNA levels and RNA interference by doxycycline induced activation of a minimal RNA polymerase III promoter. Nucleic Acids Res 2006;34:e37. [PMID: 16522642 DOI: 10.1093/nar/gkl034] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
273 Bai M, Shen M, Teng Y, Sun Y, Li F, Zhang X, Xu Y, Duan Y, Du L. Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound. Oncotarget 2015;6:43779-90. [PMID: 26575421 DOI: 10.18632/oncotarget.6085] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
274 Saayman S, Arbuthnot P, Weinberg MS. Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors. Nucleic Acids Res 2010;38:6652-63. [PMID: 20525791 DOI: 10.1093/nar/gkq460] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
275 Ralph GS, Radcliffe PA, Day DM, Carthy JM, Leroux MA, Lee DC, Wong LF, Bilsland LG, Greensmith L, Kingsman SM. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med. 2005;11:429-433. [PMID: 15768029 DOI: 10.1038/nm1205] [Cited by in Crossref: 348] [Cited by in F6Publishing: 300] [Article Influence: 21.8] [Reference Citation Analysis]
276 Amaar YG, Tapia B, Chen ST, Baylink DJ, Mohan S. Identification and characterization of novel IGFBP5 interacting protein: evidence IGFBP5-IP is a potential regulator of osteoblast cell proliferation. Am J Physiol Cell Physiol 2006;290:C900-6. [PMID: 16269403 DOI: 10.1152/ajpcell.00563.2004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
277 Lin S, Ying S. D-RNAi-Based Therapeutics. In: Los M, Gibson SB, editors. Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases. New York: Springer-Verlag; 2005. pp. 275-95. [DOI: 10.1007/0-387-23695-3_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
278 Shan T, Ren Y, Wang Y. Sirtuin 1 affects the transcriptional expression of adipose triglyceride lipase in porcine adipocytes. J Anim Sci 2013;91:1247-54. [PMID: 23296834 DOI: 10.2527/jas.2011-5030] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
279 Xia X, Pollock N, Zhou J, Rossi J. Tissue-Specific Delivery of Oligonucleotides. Methods Mol Biol 2019;2036:17-50. [PMID: 31410789 DOI: 10.1007/978-1-4939-9670-4_2] [Reference Citation Analysis]
280 Sun L, Guo RF, Gao H, Sarma JV, Zetoune FS, Ward PA. Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells. FASEB J 2009;23:3808-18. [PMID: 19620403 DOI: 10.1096/fj.09-133694] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
281 Su J, Zhu Z, Xiong F, Wang Y. Hybrid cytomegalovirus-U6 promoter-based plasmid vectors improve efficiency of RNA interference in zebrafish. Mar Biotechnol (NY) 2008;10:511-7. [PMID: 18322750 DOI: 10.1007/s10126-008-9087-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
282 Zhou J, Peng C, Li B, Wang F, Zhou C, Hong D, Ye F, Cheng X, Lü W, Xie X. Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo. Gynecol Oncol 2012;124:296-302. [PMID: 22056554 DOI: 10.1016/j.ygyno.2011.10.028] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
283 Gorbatyuk M, Justilien V, Liu J, Hauswirth WW, Lewin AS. Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery. Vision Res 2007;47:1202-8. [PMID: 17292939 DOI: 10.1016/j.visres.2006.11.026] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
284 Zou GM. RNAi in stem cells: current status and future perspectives. Methods Mol Biol 2010;650:3-14. [PMID: 20686939 DOI: 10.1007/978-1-60761-769-3_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
285 Ragozin S, Niemeier A, Laatsch A, Loeffler B, Merkel M, Beisiegel U, Heeren J. Knockdown of hepatic ABCA1 by RNA interference decreases plasma HDL cholesterol levels and influences postprandial lipemia in mice. Arterioscler Thromb Vasc Biol. 2005;25:1433-1438. [PMID: 15845910 DOI: 10.1161/01.atv.0000166616.86723.d0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
286 Rines DR, Tu B, Miraglia L, Welch GL, Zhang J, Hull MV, Orth AP, Chanda SK. High-content screening of functional genomic libraries. Methods Enzymol 2006;414:530-65. [PMID: 17110210 DOI: 10.1016/S0076-6879(06)14028-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
287 Sekar TV, Mohanram RK, Foygel K, Paulmurugan R. Therapeutic evaluation of microRNAs by molecular imaging. Theranostics 2013;3:964-85. [PMID: 24396507 DOI: 10.7150/thno.4928] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
288 Hong C, Goins WF, Goss JR, Burton EA, Glorioso JC. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-β peptide in vivo. Gene Ther 2006;13:1068-79. [DOI: 10.1038/sj.gt.3302719] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
289 Yan L, Gonca S, Zhu G, Zhang W, Chen X. Layered double hydroxide nanostructures and nanocomposites for biomedical applications. J Mater Chem B 2019;7:5583-601. [PMID: 31508652 DOI: 10.1039/c9tb01312a] [Cited by in Crossref: 35] [Cited by in F6Publishing: 3] [Article Influence: 35.0] [Reference Citation Analysis]
290 Wang Z. The guideline of the design and validation of MiRNA mimics. Methods Mol Biol. 2011;676:211-223. [PMID: 20931400 DOI: 10.1007/978-1-60761-863-8_15] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 6.9] [Reference Citation Analysis]
291 Medeiros IG, Khayat AS, Stransky B, Santos S, Assumpção P, de Souza JES. A small interfering RNA (siRNA) database for SARS-CoV-2. Sci Rep 2021;11:8849. [PMID: 33893357 DOI: 10.1038/s41598-021-88310-8] [Reference Citation Analysis]
292 Gonzalez-alegre P, Miller VM, Davidson BL, Paulson HL. Toward therapy for DYT1 dystonia: Allele-specific silencing of mutant TorsinA. Ann Neurol 2003;53:781-7. [DOI: 10.1002/ana.10548] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 3.8] [Reference Citation Analysis]
293 Fischer PM, Bell G, Midgley C, Sleigh R, Glover DM. Cell cycle target validation: approaches and successes. TARGETS 2003;2:154-61. [DOI: 10.1016/s1477-3627(03)02347-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
294 Chen W, Yan W, Du Q, Fei L, Liu M, Ni Z, Sheng Z, Zheng Z. RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice. J Virol. 2004;78:6900-6907. [PMID: 15194766 DOI: 10.1128/JVI.78.13.6900-6907.2004] [Cited by in Crossref: 90] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
295 O'connor RM, Dinan TG, Cryan JF. Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression. Mol Psychiatry 2012;17:359-76. [DOI: 10.1038/mp.2011.162] [Cited by in Crossref: 90] [Cited by in F6Publishing: 87] [Article Influence: 9.0] [Reference Citation Analysis]
296 Franich NR, Fitzsimons HL, Fong DM, Klugmann M, During MJ, Young D. AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease. Mol Ther 2008;16:947-56. [PMID: 18388917 DOI: 10.1038/mt.2008.50] [Cited by in Crossref: 108] [Cited by in F6Publishing: 98] [Article Influence: 8.3] [Reference Citation Analysis]
297 Lwin WW, Park K, Wauson M, Gao Q, Finn PW, Perkins D, Khanna A. Systems biology approach to transplant tolerance: proof of concept experiments using RNA interference (RNAi) to knock down hub genes in Jurkat and HeLa cells in vitro. J Surg Res 2012;176:e41-6. [PMID: 22342379 DOI: 10.1016/j.jss.2011.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
298 Bosch P, Pratt SL, Stice SL. Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells. Biol Reprod 2006;74:46-57. [PMID: 16162872 DOI: 10.1095/biolreprod.105.045138] [Cited by in Crossref: 116] [Cited by in F6Publishing: 102] [Article Influence: 7.3] [Reference Citation Analysis]
299 Howard KA, Kjems J. Polycation-based nanoparticle delivery for improved RNA interference therapeutics. Expert Opin Biol Ther 2007;7:1811-22. [PMID: 18034647 DOI: 10.1517/14712598.7.12.1811] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
300 Liang X, Yang X, Tang Y, Zhou H, Liu X, Xiao L, Gao J, Mao Z. RNAi-mediated downregulation of urokinase plasminogen activator receptor inhibits proliferation, adhesion, migration and invasion in oral cancer cells. Oral Oncol 2008;44:1172-80. [PMID: 18486529 DOI: 10.1016/j.oraloncology.2008.03.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
301 Su J, Zhu Z, Wang Y, Xiong F, Zou J. The Cytomegalovirus Promoter-Driven Short Hairpin RNA Constructs Mediate Effective RNA Interference in Zebrafish In Vivo. Mar Biotechnol 2008;10:262-9. [DOI: 10.1007/s10126-007-9059-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
302 Ahn M, Witting SR, Ruiz R, Saxena R, Morral N. Constitutive expression of short hairpin RNA in vivo triggers buildup of mature hairpin molecules. Hum Gene Ther 2011;22:1483-97. [PMID: 21780944 DOI: 10.1089/hum.2010.234] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
303 Kumar LD, Clarke AR. Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications. Adv Drug Deliv Rev 2007;59:87-100. [PMID: 17434644 DOI: 10.1016/j.addr.2007.03.009] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
304 Maeda Y, Sheffield AM, Smith RJ. Therapeutic regulation of gene expression in the inner ear using RNA interference. Adv Otorhinolaryngol. 2009;66:13-36. [PMID: 19494570 DOI: 10.1159/000218205] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
305 Chung KH, Hart CC, Al-Bassam S, Avery A, Taylor J, Patel PD, Vojtek AB, Turner DL. Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res. 2006;34:e53. [PMID: 16614444 DOI: 10.1093/nar/gkl143] [Cited by in Crossref: 211] [Cited by in F6Publishing: 199] [Article Influence: 14.1] [Reference Citation Analysis]
306 Mittal V. Improving the efficiency of RNA interference in mammals. Nat Rev Genet. 2004;5:355-365. [PMID: 15143318 DOI: 10.1038/nrg1323] [Cited by in Crossref: 190] [Cited by in F6Publishing: 156] [Article Influence: 11.2] [Reference Citation Analysis]
307 Saulnier A, Pelletier I, Labadie K, Colbère-Garapin F. Complete cure of persistent virus infections by antiviral siRNAs. Mol Ther 2006;13:142-50. [PMID: 16157509 DOI: 10.1016/j.ymthe.2005.07.697] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
308 Toth ZE, Shahar T, Leker R, Szalayova I, Bratincsák A, Key S, Lonyai A, Németh K, Mezey E. Sensitive detection of GFP utilizing tyramide signal amplification to overcome gene silencing. Exp Cell Res 2007;313:1943-50. [PMID: 17428464 DOI: 10.1016/j.yexcr.2007.02.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
309 Leng Q, Mixson AJ. Small interfering RNA targeting Raf-1 inhibits tumor growth in vitro and in vivo. Cancer Gene Ther 2005;12:682-90. [DOI: 10.1038/sj.cgt.7700831] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]
310 Seibler J, Schwenk F. Transgenic RNAi applications in the mouse. Methods Enzymol 2010;477:367-86. [PMID: 20699151 DOI: 10.1016/S0076-6879(10)77019-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
311 Amaar YG, Baylink DJ, Mohan S. Ras-association domain family 1 protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation. J Bone Miner Res. 2005;20:1430-1439. [PMID: 16007340 DOI: 10.1359/jbmr.050311] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
312 Miller VM, Gouvion CM, Davidson BL, Paulson HL. Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Nucleic Acids Res 2004;32:661-8. [PMID: 14754988 DOI: 10.1093/nar/gkh208] [Cited by in Crossref: 116] [Cited by in F6Publishing: 97] [Article Influence: 6.8] [Reference Citation Analysis]
313 Medarova Z, Moore A. IN VIVO IMAGING AND DELIVERY OF siRNA. In: Li C, Tian M, editors. Drug Delivery Applications of Noninvasive Imaging. Hoboken: John Wiley & Sons, Inc; 2013. pp. 199-222. [DOI: 10.1002/9781118356845.ch9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
314 Albers C, Illert AL, Miething C, Leischner H, Thiede M, Peschel C, Duyster J. An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL-driven leukemogenesis. Blood 2011;118:2200-10. [PMID: 21715303 DOI: 10.1182/blood-2010-10-309583] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
315 Kiang AS, Palfi A, Ader M, Kenna PF, Millington-Ward S, Clark G, Kennan A, O'reilly M, Tam LC, Aherne A, McNally N, Humphries P, Farrar GJ. Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approach. Mol Ther 2005;12:555-61. [PMID: 15967729 DOI: 10.1016/j.ymthe.2005.03.028] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 3.8] [Reference Citation Analysis]
316 Zhang J, Wang C, Ke N, Bliesath J, Chionis J, He QS, Li QX, Chatterton JE, Wong-Staal F, Zhou D. A more efficient RNAi inducible system for tight regulation of gene expression in mammalian cells and xenograft animals. RNA 2007;13:1375-83. [PMID: 17616554 DOI: 10.1261/rna.520707] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
317 Gonzalez-alegre P. Therapeutic RNA interference for neurodegenerative diseases: From promise to progress. Pharmacology & Therapeutics 2007;114:34-55. [DOI: 10.1016/j.pharmthera.2007.01.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
318 Raja MAG, Katas H, Amjad MW. Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA. Asian J Pharm Sci 2019;14:497-510. [PMID: 32104477 DOI: 10.1016/j.ajps.2018.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
319 Wang Z, Rao DD, Senzer N, Nemunaitis J. RNA interference and cancer therapy. Pharm Res 2011;28:2983-95. [PMID: 22009588 DOI: 10.1007/s11095-011-0604-5] [Cited by in Crossref: 96] [Cited by in F6Publishing: 77] [Article Influence: 9.6] [Reference Citation Analysis]
320 Li L, Wang F, Wu Y, Davidson G, Levkin PA. Combinatorial Synthesis and High-Throughput Screening of Alkyl Amines for Nonviral Gene Delivery. Bioconjugate Chem 2013;24:1543-51. [DOI: 10.1021/bc400158w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
321 Hamazaki H, Takahashi H, Shimotohno K, Miyano-Kurosaki N, Takaku H. Inhibition of hcv replication in HCV replicon by shRNAs. Nucleosides Nucleotides Nucleic Acids 2006;25:801-5. [PMID: 16898418 DOI: 10.1080/15257770600726091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
322 Cazzin C, Zanderigo F, Costantini VJ, Zambello E, Ring CJ, Morrison AD, Caberlotto L, Kew JN. Adenoviral-mediated Cre expression effectively suppresses GlyT1 binding in the thalamic area of GlyT1 conditional knock-out mice. J Neurosci Methods 2010;193:254-63. [PMID: 20832426 DOI: 10.1016/j.jneumeth.2010.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
323 Gondi CS, Lakka SS, Dinh DH, Olivero WC, Gujrati M, Rao JS. RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene. 2004;23:8486-8496. [PMID: 15378018 DOI: 10.1038/sj.onc.1207879] [Cited by in Crossref: 99] [Cited by in F6Publishing: 90] [Article Influence: 5.8] [Reference Citation Analysis]
324 Nielsen TT, Mizielinska S, Hasholt L, Isaacs AM, Nielsen JE; FReJA Consortium. Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference. J Gene Med 2012;14:521-9. [PMID: 22786763 DOI: 10.1002/jgm.2649] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
325 Lenz G. The RNA interference revolution. Braz J Med Biol Res. 2005;38:1749-1757. [PMID: 16302089 DOI: 10.1590/S0100-879X2005001200003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
326 Zenke K, Nam YK, Kim KH. Development of siRNA expression vector utilizing rock bream β-actin promoter: a potential therapeutic tool against viral infection in fish. Appl Microbiol Biotechnol 2010;85:679-90. [DOI: 10.1007/s00253-009-2177-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
327 Zhang W, Zhou Y, Li X, Xu X, Chen Y, Zhu R, Yin L. Macrophage-targeting and reactive oxygen species (ROS)-responsive nanopolyplexes mediate anti-inflammatory siRNA delivery against acute liver failure (ALF). Biomater Sci 2018;6:1986-93. [DOI: 10.1039/c8bm00389k] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 7.7] [Reference Citation Analysis]
328 Weber W, Malphettes L, Rinderknecht M, Schoenmakers RG, Spielmann M, Keller B, Van de Wetering P, Weber CC, Fussenegger M. Quorum-Sensing-Based Toolbox for Regulatable Transgene and siRNA Expression in Mammalian Cells. Biotechnol Progress 2005;21:178-85. [DOI: 10.1021/bp0498995] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
329 Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature. 2006;441:537-541. [PMID: 16724069 DOI: 10.1038/nature04791] [Cited by in Crossref: 1155] [Cited by in F6Publishing: 1045] [Article Influence: 77.0] [Reference Citation Analysis]
330 Aagaard L, Rossi JJ. RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev. 2007;59:75-86. [PMID: 17449137 DOI: 10.1016/j.addr.2007.03.005] [Cited by in Crossref: 589] [Cited by in F6Publishing: 516] [Article Influence: 42.1] [Reference Citation Analysis]
331 Vanderbyl S, Macdonald GN, Sidhu S, Gung L, Telenius A, Perez C, Perkins E. Transfer and Stable Transgene Expression of a Mammalian Artificial Chromosome into Bone Marrow-Derived Human Mesenchymal Stem Cells: Transfer and Stable Transgene Expression of a Mammalian Artificial Chromosome into Bone Marrow-Derived Human Mesenchymal Stem Cells. STEM CELLS 2004;22:324-33. [DOI: 10.1634/stemcells.22-3-324] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
332 Zhu LJ, Yan WX, Chen ZW, Chen Y, Chen D, Zhang TH, Liao GQ. Disruption of mediator complex subunit 19 (Med19) inhibits cell growth and migration in tongue cancer. World J Surg Oncol 2013;11:116. [PMID: 23705783 DOI: 10.1186/1477-7819-11-116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
333 Zhou Y, Chan JH, Chan AY, Chak RK, Wong EY, Chye ML, Peiris JS, Poon LL, Lam E. Transgenic plant-derived siRNAs can suppress propagation of influenza virus in mammalian cells. FEBS Lett 2004;577:345-50. [PMID: 15556607 DOI: 10.1016/j.febslet.2004.10.027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
334 Hacker DL, Bertschinger M, Baldi L, Wurm FM. Reduction of adenovirus E1A mRNA by RNAi results in enhanced recombinant protein expression in transiently transfected HEK293 cells. Gene 2004;341:227-34. [DOI: 10.1016/j.gene.2004.06.054] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
335 Baisakh N, Subudhi PK, Varadwaj P. Primary responses to salt stress in a halophyte, smooth cordgrass (Spartina alterniflora Loisel.). Funct Integr Genomics 2008;8:287-300. [PMID: 18305970 DOI: 10.1007/s10142-008-0075-x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
336 van Bilsen PH, Jaspers L, Lombardi MS, Odekerken JC, Burright EN, Kaemmerer WF. Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts. Hum Gene Ther 2008;19:710-9. [PMID: 18549309 DOI: 10.1089/hum.2007.116] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 6.8] [Reference Citation Analysis]
337 Ge Q, Eisen HN, Chen J. Use of siRNAs to prevent and treat influenza virus infection. Virus Res. 2004;102:37-42. [PMID: 15068878 DOI: 10.1016/j.virusres.2004.01.013] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
338 Dai W, He W, Shang G, Jiang J, Wang Y, Kong W. Gene silencing of myofibrillogenesis regulator-1 by adenovirus-delivered small interfering RNA suppresses cardiac hypertrophy induced by angiotensin II in mice. American Journal of Physiology-Heart and Circulatory Physiology 2010;299:H1468-75. [DOI: 10.1152/ajpheart.00582.2009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
339 Tufro A. Morpholino-mediated gene knockdown in mammalian organ culture. Methods Mol Biol 2012;886:305-9. [PMID: 22639272 DOI: 10.1007/978-1-61779-851-1_27] [Reference Citation Analysis]
340 Hughes J, Yadava P, Mesaros R. Liposomal siRNA Delivery. In: Weissig V, editor. Liposomes. Totowa: Humana Press; 2010. pp. 445-59. [DOI: 10.1007/978-1-60327-360-2_31] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
341 Jian R, Peng T, Deng S, Jiang J, Hu F, An J, Cheng X. A simple strategy for generation of gene knockdown constructs with convergent H1 and U6 promoters. Eur J Cell Biol 2006;85:433-40. [PMID: 16337710 DOI: 10.1016/j.ejcb.2005.10.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
342 Wang TB, Huang WS, Lin WH, Shi HP, Dong WG. Inhibition of KIT RNAi mediated with adenovirus in gastrointestinal stromal tumor xenograft. World J Gastroenterol 2010;16:5122-9. [PMID: 20976851 DOI: 10.3748/wjg.v16.i40.5122] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
343 Ramachandran PV, Ignacimuthu S. RNA interference--a silent but an efficient therapeutic tool. Appl Biochem Biotechnol 2013;169:1774-89. [PMID: 23340870 DOI: 10.1007/s12010-013-0098-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
344 Wagner JL, O'Connor DM, Donsante A, Boulis NM. Gene, Stem Cell, and Alternative Therapies for SCA 1. Front Mol Neurosci 2016;9:67. [PMID: 27570504 DOI: 10.3389/fnmol.2016.00067] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
345 Usuki F, Yamashita A, Kashima I, Higuchi I, Osame M, Ohno S. Specific inhibition of nonsense-mediated mRNA decay components, SMG-1 or Upf1, rescues the phenotype of ullrich disease fibroblasts. Molecular Therapy 2006;14:351-60. [DOI: 10.1016/j.ymthe.2006.04.011] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
346 Esau CC, Monia BP. Therapeutic potential for microRNAs. Advanced Drug Delivery Reviews 2007;59:101-14. [DOI: 10.1016/j.addr.2007.03.007] [Cited by in Crossref: 134] [Cited by in F6Publishing: 127] [Article Influence: 9.6] [Reference Citation Analysis]
347 Ding H, Schwarz DS, Keene A, Affar EB, Fenton L, Xia X, Shi Y, Zamore PD, Xu Z. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2003;2:209-17. [DOI: 10.1046/j.1474-9728.2003.00054.x] [Cited by in Crossref: 124] [Cited by in F6Publishing: 106] [Article Influence: 6.9] [Reference Citation Analysis]
348 Luan X, Guo L, Yang Z, Liu M, Li X, Tang H. Specific expression of short-interfering RNA driven by human telomerase reverse transcriptase promoter in tumor cells. Acta Biochim Biophys Sin (Shanghai) 2008;40:928-33. [PMID: 18989573 DOI: 10.1111/j.1745-7270.2008.00475.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
349 Trejo-ávila; L, Elizondo-gonzález; R, del C. Trujillo-murillo; K, Zapata-benavides; P, Rodríguez-padilla; C, María Rivas-estilla A. Antiviral therapy: Inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the Viral Genome. Annals of Hepatology 2007;6:174-80. [DOI: 10.1016/s1665-2681(19)31925-8] [Cited by in Crossref: 9] [Article Influence: 0.6] [Reference Citation Analysis]
350 Singer O, Yanai A, Verma IM. Silence of the genes. Proc Natl Acad Sci U S A 2004;101:5313-4. [PMID: 15067116 DOI: 10.1073/pnas.0401209101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
351 Zakaria MK, Khan I, Mani P, Chattopadhyay P, Sarkar DP, Sinha S. Combination of hepatocyte specific delivery and transformation dependent expression of shRNA inducing transcriptional gene silencing of c-Myc promoter in hepatocellular carcinoma cells. BMC Cancer. 2014;14:582. [PMID: 25108398 DOI: 10.1186/1471-2407-14-582] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
352 Lasek AW, Janak PH, He L, Whistler JL, Heberlein U. Downregulation of mu opioid receptor by RNA interference in the ventral tegmental area reduces ethanol consumption in mice. Genes, Brain and Behavior 2007;6:728-35. [DOI: 10.1111/j.1601-183x.2007.00303.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
353 Lee SK, Dykxhoorn DM, Kumar P, Ranjbar S, Song E, Maliszewski LE, François-Bongarçon V, Goldfeld A, Swamy NM, Lieberman J, Shankar P. Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood. 2005;106:818-826. [PMID: 15831707 DOI: 10.1182/blood-2004-10-3959] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 4.4] [Reference Citation Analysis]
354 Davidson BL, Boudreau RL. RNA Interference: A Tool for Querying Nervous System Function and an Emerging Therapy. Neuron 2007;53:781-8. [DOI: 10.1016/j.neuron.2007.02.020] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
355 Yang Y, Kaul S, Zhang D, Anantharam V, Kanthasamy AG. Suppression of caspase-3-dependent proteolytic activation of protein kinase C delta by small interfering RNA prevents MPP+-induced dopaminergic degeneration. Mol Cell Neurosci 2004;25:406-21. [PMID: 15033169 DOI: 10.1016/j.mcn.2003.11.011] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 2.9] [Reference Citation Analysis]
356 Love DR, Lan C, Dodd A, Shelling AN, Mcnabb WC, Ferguson LR. Modeling inflammatory bowel disease: the zebrafish as a way forward. Expert Review of Molecular Diagnostics 2014;7:177-93. [DOI: 10.1586/14737159.7.2.177] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
357 Li H, Fu X, Chen Y, Hong Y, Tan Y, Cao H, Wu M, Wang H. Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma. Gastroenterology. 2005;128:2029-2041. [PMID: 15940635 DOI: 10.1053/j.gastro.2005.03.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 4.4] [Reference Citation Analysis]
358 Perrin-Tricaud C, Rutishauser U, Tricaud N. P120 catenin is required for thickening of Schwann cell myelin. Mol Cell Neurosci 2007;35:120-9. [PMID: 17382558 DOI: 10.1016/j.mcn.2007.02.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
359 Yang G, Huang C, Cao J, Huang KJ, Jiang T, Qiu ZJ. Lentivirus-mediated shRNA interference targeting STAT3 inhibits human pancreatic cancer cell invasion. World J Gastroenterol 2009;15:3757-66. [PMID: 19673016 DOI: 10.3748/wjg.15.3757] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
360 Denti MA, Rosa A, Sthandier O, De Angelis FG, Bozzoni I. A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells. Mol Ther. 2004;10:191-199. [PMID: 15272480 DOI: 10.1016/j.ymthe.2004.04.008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
361 Tanaka T, Mangala LS, Vivas-Mejia PE, Nieves-Alicea R, Mann AP, Mora E, Han HD, Shahzad MM, Liu X, Bhavane R, Gu J, Fakhoury JR, Chiappini C, Lu C, Matsuo K, Godin B, Stone RL, Nick AM, Lopez-Berestein G, Sood AK, Ferrari M. Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res 2010;70:3687-96. [PMID: 20430760 DOI: 10.1158/0008-5472.CAN-09-3931] [Cited by in Crossref: 255] [Cited by in F6Publishing: 88] [Article Influence: 23.2] [Reference Citation Analysis]
362 Harborth J, Elbashir SM, Vandenburgh K, Manninga H, Scaringe SA, Weber K, Tuschl T. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense. Nucleic Acid Drug Dev. 2003;13:83-105. [PMID: 12804036 DOI: 10.1089/108729003321629638] [Cited by in Crossref: 324] [Cited by in F6Publishing: 303] [Article Influence: 18.0] [Reference Citation Analysis]
363 McCown M, Diamond MS, Pekosz A. The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses. Virology 2003;313:514-24. [PMID: 12954218 DOI: 10.1016/s0042-6822(03)00341-6] [Cited by in Crossref: 65] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
364 Moore CB, Guthrie EH, Huang MT, Taxman DJ. Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown. Methods Mol Biol 2010;629:141-58. [PMID: 20387148 DOI: 10.1007/978-1-60761-657-3_10] [Cited by in Crossref: 34] [Cited by in F6Publishing: 72] [Article Influence: 3.1] [Reference Citation Analysis]
365 Kelley K, Chang SJ, Lin SL. Mechanism of repeat-associated microRNAs in fragile X syndrome. Neural Plast 2012;2012:104796. [PMID: 22779005 DOI: 10.1155/2012/104796] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
366 Duennwald ML, Jagadish S, Giorgini F, Muchowski PJ, Lindquist S. A network of protein interactions determines polyglutamine toxicity. Proc Natl Acad Sci U S A 2006;103:11051-6. [PMID: 16832049 DOI: 10.1073/pnas.0604548103] [Cited by in Crossref: 110] [Cited by in F6Publishing: 100] [Article Influence: 7.3] [Reference Citation Analysis]
367 Zhang Y, Cristofaro P, Silbermann R, Pusch O, Boden D, Konkin T, Hovanesian V, Monfils PR, Resnick M, Moss SF, Ramratnam B. Engineering mucosal RNA interference in vivo. Mol Ther 2006;14:336-42. [PMID: 16766229 DOI: 10.1016/j.ymthe.2006.04.001] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 4.5] [Reference Citation Analysis]
368 Takigawa Y, Nagano-Fujii M, Deng L, Hidajat R, Tanaka M, Mizuta H, Hotta H. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome. Microbiol Immunol. 2004;48:591-598. [PMID: 15322339 DOI: 10.1111/j.1348-0421.2004.tb03556.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.0] [Reference Citation Analysis]
369 Ghahramani Seno MM, Graham IR, Athanasopoulos T, Trollet C, Pohlschmidt M, Crompton MR, Dickson G. RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathology. Human Molecular Genetics 2008;17:2622-32. [DOI: 10.1093/hmg/ddn162] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
370 Gandra N, Wang DD, Zhu Y, Mao C. Virus-mimetic cytoplasm-cleavable magnetic/silica nanoclusters for enhanced gene delivery to mesenchymal stem cells. Angew Chem Int Ed Engl 2013;52:11278-81. [PMID: 24038718 DOI: 10.1002/anie.201301113] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
371 Garwick-Coppens SE, Herman A, Harper SQ. Construction of permanently inducible miRNA-based expression vectors using site-specific recombinases. BMC Biotechnol 2011;11:107. [PMID: 22087765 DOI: 10.1186/1472-6750-11-107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
372 Yin L, Song Z, Qu Q, Kim KH, Zheng N, Yao C, Chaudhury I, Tang H, Gabrielson NP, Uckun FM, Cheng J. Supramolecular self-assembled nanoparticles mediate oral delivery of therapeutic TNF-α siRNA against systemic inflammation. Angew Chem Int Ed Engl 2013;52:5757-61. [PMID: 23610013 DOI: 10.1002/anie.201209991] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 9.0] [Reference Citation Analysis]
373 Chen LX, Lin L, Wang HJ, Wei XL, Fu X, Zhang JY, Yu CL. Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA. Osteoarthritis Cartilage 2008;16:174-84. [PMID: 17686636 DOI: 10.1016/j.joca.2007.06.006] [Cited by in Crossref: 90] [Cited by in F6Publishing: 83] [Article Influence: 6.4] [Reference Citation Analysis]
374 Mat Jalaluddin NS, Othman RY, Harikrishna JA. Global trends in research and commercialization of exogenous and endogenous RNAi technologies for crops. Critical Reviews in Biotechnology 2019;39:67-78. [DOI: 10.1080/07388551.2018.1496064] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
375 Tompkins SM, Lo CY, Tumpey TM, Epstein SL. Protection against lethal influenza virus challenge by RNA interference in vivo. Proc Natl Acad Sci U S A 2004;101:8682-6. [PMID: 15173583 DOI: 10.1073/pnas.0402630101] [Cited by in Crossref: 259] [Cited by in F6Publishing: 230] [Article Influence: 15.2] [Reference Citation Analysis]
376 Kovar H, Ban J, Pospisilova S. Potentials for RNAi in sarcoma research and therapy: Ewing’s sarcoma as a model. Seminars in Cancer Biology 2003;13:275-81. [DOI: 10.1016/s1044-579x(03)00041-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
377 Crook ZR, Housman DE. Dysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model mice. Proc Natl Acad Sci U S A 2012;109:7487-92. [PMID: 22529362 DOI: 10.1073/pnas.1204542109] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
378 Lu PY, Xie F, Woodle MC. In vivo application of RNA interference: from functional genomics to therapeutics. Adv Genet 2005;54:117-42. [PMID: 16096010 DOI: 10.1016/S0065-2660(05)54006-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 37] [Article Influence: 0.8] [Reference Citation Analysis]
379 Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 2005;12:461-466. [PMID: 15616603 DOI: 10.1038/sj.gt.3302425] [Cited by in Crossref: 522] [Cited by in F6Publishing: 444] [Article Influence: 32.6] [Reference Citation Analysis]
380 Dittgen T, Nimmerjahn A, Komai S, Licznerski P, Waters J, Margrie TW, Helmchen F, Denk W, Brecht M, Osten P. Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proc Natl Acad Sci U S A 2004;101:18206-11. [PMID: 15608064 DOI: 10.1073/pnas.0407976101] [Cited by in Crossref: 331] [Cited by in F6Publishing: 295] [Article Influence: 19.5] [Reference Citation Analysis]
381 Cazzin C, Ring CJ. Recent advances in the manipulation of murine gene expression and its utility for the study of human neurological disease. Biochim Biophys Acta 2010;1802:796-807. [PMID: 20004244 DOI: 10.1016/j.bbadis.2009.11.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
382 Couturier C, Sarkis C, Séron K, Belouzard S, Chen P, Lenain A, Corset L, Dam J, Vauthier V, Dubart A, Mallet J, Froguel P, Rouillé Y, Jockers R. Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents diet-induced obesity. Proc Natl Acad Sci U S A 2007;104:19476-81. [PMID: 18042720 DOI: 10.1073/pnas.0706671104] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 5.2] [Reference Citation Analysis]
383 Tiscornia G, Singer O, Ikawa M, Verma IM. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA. 2003;100:1844-1848. [PMID: 12552109 DOI: 10.1073/pnas.0437912100] [Cited by in Crossref: 397] [Cited by in F6Publishing: 353] [Article Influence: 22.1] [Reference Citation Analysis]
384 Lu KK, Armstrong SE, Ginnan R, Singer HA. Adhesion-dependent activation of CaMKII and regulation of ERK activation in vascular smooth muscle. Am J Physiol Cell Physiol 2005;289:C1343-50. [PMID: 15944210 DOI: 10.1152/ajpcell.00064.2005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
385 Keiser MS, Boudreau RL, Davidson BL. Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy. Mol Ther 2014;22:588-95. [PMID: 24419082 DOI: 10.1038/mt.2013.279] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
386 Patil VS, Zhou R, Rana TM. Gene regulation by non-coding RNAs. Crit Rev Biochem Mol Biol 2014;49:16-32. [PMID: 24164576 DOI: 10.3109/10409238.2013.844092] [Cited by in Crossref: 91] [Cited by in F6Publishing: 74] [Article Influence: 11.4] [Reference Citation Analysis]
387 Steffan JS, Thompson LM. Targeting aggregation in the development of therapeutics for the treatment of Huntington's disease and other polyglutamine repeat diseases. Expert Opin Ther Targets 2003;7:201-13. [PMID: 12667098 DOI: 10.1517/14728222.7.2.201] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
388 Robson MG, Sacks SH. RNA interference--a new experimental and therapeutic tool. Curr Opin Nephrol Hypertens 2005;14:558-60. [PMID: 16205475 DOI: 10.1097/01.mnh.0000168937.41270.34] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
389 Abrahamyan A, Nagy É, Golovan SP. Human H1 promoter expressed short hairpin RNAs (shRNAs) suppress avian influenza virus replication in chicken CH-SAH and canine MDCK cells. Antiviral Research 2009;84:159-67. [DOI: 10.1016/j.antiviral.2009.08.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
390 Li M, Qian H, Ichim TE, Ge WW, Popov IA, Rycerz K, Neu J, White D, Zhong R, Min WP. Induction of RNA interference in dendritic cells. Immunol Res 2004;30:215-30. [PMID: 15477662 DOI: 10.1385/IR:30:2:215] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
391 Mäkinen PI, Koponen JK, Kärkkäinen AM, Malm TM, Pulkkinen KH, Koistinaho J, Turunen MP, Ylä-Herttuala S. Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain. J Gene Med. 2006;8:433-441. [PMID: 16389634 DOI: 10.1002/jgm.860] [Cited by in Crossref: 93] [Cited by in F6Publishing: 76] [Article Influence: 6.2] [Reference Citation Analysis]
392 de los Santos T, Wu Q, de Avila Botton S, Grubman MJ. Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus. Virology 2005;335:222-31. [PMID: 15840521 DOI: 10.1016/j.virol.2005.03.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
393 Dutta S, Bhaduri N, Rastogi N, Chandel SG, Vandavasi JK, Upadhayaya RS, Chattopadhyaya J. Carba-LNA modified siRNAs targeting HIV-1 TAR region downregulate HIV-1 replication successfully with enhanced potency. Med Chem Commun 2011;2:206. [DOI: 10.1039/c0md00225a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
394 Gong P, Sun L, Wang F, Liu X, Yan Z, Wang M, Zhang L, Tian Z, Liu Z, You J. Highly fluorescent N-doped carbon dots with two-photon emission for ultrasensitive detection of tumor marker and visual monitor anticancer drug loading and delivery. Chemical Engineering Journal 2019;356:994-1002. [DOI: 10.1016/j.cej.2018.09.100] [Cited by in Crossref: 81] [Cited by in F6Publishing: 44] [Article Influence: 40.5] [Reference Citation Analysis]
395 Kusumoto K. Structural features of glutamate-based lipidic materials for small interfering RNA delivery system. J Biomed Mater Res 2009;89A:739-50. [DOI: 10.1002/jbm.a.32026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
396 Armakola M, Higgins MJ, Figley MD, Barmada SJ, Scarborough EA, Diaz Z, Fang X, Shorter J, Krogan NJ, Finkbeiner S. Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat Genet. 2012;44:1302-1309. [PMID: 23104007 DOI: 10.1038/ng.2434] [Cited by in Crossref: 141] [Cited by in F6Publishing: 141] [Article Influence: 15.7] [Reference Citation Analysis]
397 Ralph GS, Mazarakis ND, Azzouz M. Therapeutic gene silencing in neurological disorders, using interfering RNA. J Mol Med (Berl) 2005;83:413-9. [PMID: 15759100 DOI: 10.1007/s00109-005-0649-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
398 Zhang B, Wang Y, Liu K, Yang X, Song M, Wang Y, Bai Y. Adenovirus-mediated transfer of siRNA against peroxiredoxin I enhances the radiosensitivity of human intestinal cancer. Biochemical Pharmacology 2008;75:660-7. [DOI: 10.1016/j.bcp.2007.09.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
399 Pedone E, Postiglione L, Aulicino F, Rocca DL, Montes-Olivas S, Khazim M, di Bernardo D, Pia Cosma M, Marucci L. A tunable dual-input system for on-demand dynamic gene expression regulation. Nat Commun 2019;10:4481. [PMID: 31578371 DOI: 10.1038/s41467-019-12329-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
400 Saito T, Tabata Y. Preparation of gelatin hydrogels incorporating small interfering RNA for the controlled release. Journal of Drug Targeting 2012;20:864-72. [DOI: 10.3109/1061186x.2012.725170] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
401 Zhang Z, Weinschenk T, Guo K, Schluesener HJ. siRNA binding proteins of microglial cells: PKR is an unanticipated ligand. J Cell Biochem 2006;97:1217-29. [PMID: 16315288 DOI: 10.1002/jcb.20716] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
402 Costa PM, Pedroso de Lima MC. MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression. Pharmaceuticals (Basel) 2013;6:1195-220. [PMID: 24275848 DOI: 10.3390/ph6101195] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
403 Kakutani K, Nishida K, Uno K, Takada T, Shimomura T, Maeno K, Kurosaka M, Doita M. Prolonged down regulation of specific gene expression in nucleus pulposus cell mediated by RNA interference in vitro. J Orthop Res 2006;24:1271-8. [DOI: 10.1002/jor.20171] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
404 Wurdinger T, Costa FF. Molecular therapy in the microRNA era. Pharmacogenomics J. 2007;7:297-304. [PMID: 17189960 DOI: 10.1038/sj.tpj.6500429] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.7] [Reference Citation Analysis]
405 Sapru MK, Yates JW, Hogan S, Jiang L, Halter J, Bohn MC. Silencing of human α-synuclein in vitro and in rat brain using lentiviral-mediated RNAi. Experimental Neurology 2006;198:382-90. [DOI: 10.1016/j.expneurol.2005.12.024] [Cited by in Crossref: 117] [Cited by in F6Publishing: 103] [Article Influence: 7.8] [Reference Citation Analysis]
406 Allen D, Kenna PF, Palfi A, McMahon HP, Millington-Ward S, O'Reilly M, Humphries P, Farrar GJ. Development of strategies for conditional RNA interference. J Gene Med 2007;9:287-98. [PMID: 17397092 DOI: 10.1002/jgm.1018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
407 Zhitnyak IY, Bychkov IN, Sukhorukova IV, Kovalskii AM, Firestein KL, Golberg D, Gloushankova NA, Shtansky DV. Effect of BN Nanoparticles Loaded with Doxorubicin on Tumor Cells with Multiple Drug Resistance. ACS Appl Mater Interfaces 2017;9:32498-508. [DOI: 10.1021/acsami.7b08713] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
408 Caplen NJ. Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference. Gene Ther 2004;11:1241-8. [PMID: 15292914 DOI: 10.1038/sj.gt.3302324] [Cited by in Crossref: 87] [Cited by in F6Publishing: 70] [Article Influence: 5.1] [Reference Citation Analysis]
409 Satriotomo I, Bowen KK, Vemuganti R. JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia. J Neurochem 2006;98:1353-68. [PMID: 16923154 DOI: 10.1111/j.1471-4159.2006.04051.x] [Cited by in Crossref: 136] [Cited by in F6Publishing: 139] [Article Influence: 9.1] [Reference Citation Analysis]
410 Xia XG, Zhou H, Ding H, Affar el B, Shi Y, Xu Z. An enhanced U6 promoter for synthesis of short hairpin RNA. Nucleic Acids Res 2003;31:e100. [PMID: 12930974 DOI: 10.1093/nar/gng098] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 3.5] [Reference Citation Analysis]
411 Guo S, Huang Y, Jiang Q, Sun Y, Deng L, Liang Z, Du Q, Xing J, Zhao Y, Wang PC, Dong A, Liang XJ. Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. ACS Nano 2010;4:5505-11. [PMID: 20707386 DOI: 10.1021/nn101638u] [Cited by in Crossref: 300] [Cited by in F6Publishing: 246] [Article Influence: 30.0] [Reference Citation Analysis]
412 Alexander LM, Sánchez-martín RM, Bradley M. Knocking (Anti)-Sense into Cells: The Microsphere Approach to Gene Silencing. Bioconjugate Chem 2009;20:422-6. [DOI: 10.1021/bc800529r] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
413 Lee JS, Reiner NE. Stable Lentiviral Vector-Mediated Gene Silencing in Human Monocytic Cell Lines. In: Reiner NE, editor. Macrophages and Dendritic Cells. Totowa: Humana Press; 2009. pp. 287-300. [DOI: 10.1007/978-1-59745-396-7_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
414 Liu SQ. Cardiac Protective Engineering. J Biomech Eng 2019. [PMID: 30958522 DOI: 10.1115/1.4043434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
415 Huang S, Chen L, Libina N, Janes J, Martin GM, Campisi J, Oshima J. Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference. Hum Genet 2005;118:444-50. [DOI: 10.1007/s00439-005-0051-7] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.1] [Reference Citation Analysis]
416 Morris K, Castanotto D, Al-Kadhimi Z, Jensen M, Rossi J, Cooper LJ. Enhancing siRNA effects in T cells for adoptive immunotherapy. Hematology 2005;10:461-7. [PMID: 16321811 DOI: 10.1080/10245330500233569] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
417 Ghildiyal M, Zamore PD. Small silencing RNAs: an expanding universe. Nat Rev Genet. 2009;10:94-108. [PMID: 19148191 DOI: 10.1038/nrg2504] [Cited by in Crossref: 1569] [Cited by in F6Publishing: 1356] [Article Influence: 130.8] [Reference Citation Analysis]
418 Malphettes L, Fussenegger M. Impact of RNA interference on gene networks. Metab Eng 2006;8:672-83. [PMID: 16996764 DOI: 10.1016/j.ymben.2006.07.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
419 Fukuyama S, Yoshino I, Yamaguchi M, Osoegawa A, Kameyama T, Tagawa T, Maehara Y. Blockage of the macrophage migration inhibitory factor expression by short interference RNA inhibited the rejection of an allogeneic tracheal graft. Transpl Int 2005;18:1203-9. [PMID: 16162108 DOI: 10.1111/j.1432-2277.2005.00197.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
420 Lee DF, Su J, Sevilla A, Gingold J, Schaniel C, Lemischka IR. Combining competition assays with genetic complementation strategies to dissect mouse embryonic stem cell self-renewal and pluripotency. Nat Protoc 2012;7:729-48. [PMID: 22441292 DOI: 10.1038/nprot.2012.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
421 An DS, Xie Y, Mao SH, Morizono K, Kung SK, Chen IS. Efficient lentiviral vectors for short hairpin RNA delivery into human cells. Hum Gene Ther. 2003;14:1207-1212. [PMID: 12908971 DOI: 10.1089/104303403322168037] [Cited by in Crossref: 74] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
422 Alisky JM, Davidson BL. Towards Therapy Using RNA Interference: . American Journal of PharmacoGenomics 2004;4:45-51. [DOI: 10.2165/00129785-200404010-00005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
423 Tang W, Weidner DA, Hu BY, Newton RJ, Hu X. Efficient delivery of small interfering RNA to plant cells by a nanosecond pulsed laser-induced stress wave for posttranscriptional gene silencing. Plant Science 2006;171:375-81. [DOI: 10.1016/j.plantsci.2006.04.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
424 Baba K, Mizukoshi F, Goto-Koshino Y, Setoguchi-Mukai A, Fujino Y, Ohno K, Tsujimoto H. Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines. Vet Microbiol 2007;120:207-16. [PMID: 17125939 DOI: 10.1016/j.vetmic.2006.10.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
425 Davidson BL, Harper SQ. Viral delivery of recombinant short hairpin RNAs. Methods Enzymol 2005;392:145-73. [PMID: 15644180 DOI: 10.1016/S0076-6879(04)92009-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
426 Mallucci G, Collinge J. Rational targeting for prion therapeutics. Nat Rev Neurosci 2005;6:23-34. [PMID: 15611724 DOI: 10.1038/nrn1584] [Cited by in Crossref: 69] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
427 Hadsell DL. Genetic Manipulation of Mammary Gland Development and Lactation. In: Pickering LK, Morrow AL, Ruiz-palacios GM, Schanler RJ, editors. Protecting Infants through Human Milk. Boston: Springer US; 2004. pp. 229-51. [DOI: 10.1007/978-1-4757-4242-8_20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
428 Boudreau RL, Martins I, Davidson BL. Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Mol Ther 2009;17:169-75. [PMID: 19002161 DOI: 10.1038/mt.2008.231] [Cited by in Crossref: 250] [Cited by in F6Publishing: 219] [Article Influence: 19.2] [Reference Citation Analysis]
429 Nishitsuji H, Ikeda T, Miyoshi H, Ohashi T, Kannagi M, Masuda T. Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells. Microbes Infect. 2004;6:76-85. [PMID: 14738896 DOI: 10.1016/j.micinf.2003.10.009] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
430 Gürlevik E, Woller N, Schache P, Malek NP, Wirth TC, Zender L, Manns MP, Kubicka S, Kühnel F. p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication. Nucleic Acids Res 2009;37:e84. [PMID: 19443444 DOI: 10.1093/nar/gkp374] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
431 He Y, Ju C, Zhang X. Roles of small RNAs in the immune defense mechanisms of crustaceans. Mol Immunol 2015;68:399-403. [PMID: 26210184 DOI: 10.1016/j.molimm.2015.07.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
432 Muller RY, Hammond MC, Rio DC, Lee YJ. An Efficient Method for Electroporation of Small Interfering RNAs into ENCODE Project Tier 1 GM12878 and K562 Cell Lines. J Biomol Tech 2015;26:142-9. [PMID: 26543439 DOI: 10.7171/jbt.15-2604-003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
433 De Paula D, Bentley MV, Mahato RI. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting. RNA. 2007;13:431-456. [PMID: 17329355 DOI: 10.1261/rna.459807] [Cited by in Crossref: 170] [Cited by in F6Publishing: 148] [Article Influence: 12.1] [Reference Citation Analysis]
434 Ren JL, Pan JS, Cheng T, Dong J, Lu YP, Huang SJ, Shi HX, Wang L, Lian YM. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells. Chin Dig Dis 2006;7:230-6. [DOI: 10.1111/j.1443-9573.2006.00268.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
435 Kittler R, Buchholz F. RNA interference: gene silencing in the fast lane. Seminars in Cancer Biology 2003;13:259-65. [DOI: 10.1016/s1044-579x(03)00039-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
436 Andi Brisibe E, Okada N, Mizukami H, Okuyama H, Fujii YR. RNA interference: potentials for the prevention of HIV infections and the challenges ahead. Trends in Biotechnology 2003;21:306-11. [DOI: 10.1016/s0167-7799(03)00118-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
437 Jandial R, Singec I, Ames CP, Snyder EY. Genetic modification of neural stem cells. Mol Ther 2008;16:450-7. [PMID: 18253153 DOI: 10.1038/sj.mt.6300402] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
438 Karagiannis TC, El-Osta A. RNA interference and potential therapeutic applications of short interfering RNAs. Cancer Gene Ther. 2005;12:787-795. [PMID: 15891770 DOI: 10.1038/sj.cgt.7700857] [Cited by in Crossref: 89] [Cited by in F6Publishing: 74] [Article Influence: 5.9] [Reference Citation Analysis]
439 Laatsch A, Ragozin S, Grewal T, Beisiegel U, Joerg H. Differential RNA interference: replacement of endogenous with recombinant low density lipoprotein receptor-related protein (LRP). Eur J Cell Biol 2004;83:113-20. [PMID: 15202569 DOI: 10.1078/0171-9335-00364] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
440 Stevenson M. Dissecting HIV-1 through RNA interference. Nat Rev Immunol. 2003;3:851-858. [PMID: 14557816 DOI: 10.1038/nri1227] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
441 Yokota T, Sakamoto N, Enomoto N, Tanabe Y, Miyagishi M, Maekawa S, Yi L, Kurosaki M, Taira K, Watanabe M. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep. 2003;4:602-608. [PMID: 12740604 DOI: 10.1038/sj.embor.embor840] [Cited by in Crossref: 221] [Cited by in F6Publishing: 208] [Article Influence: 13.0] [Reference Citation Analysis]
442 Zhou H, Xia XG, Xu Z. An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi. Nucleic Acids Res. 2005;33:e62. [PMID: 15805121 DOI: 10.1093/nar/gni061] [Cited by in Crossref: 113] [Cited by in F6Publishing: 103] [Article Influence: 7.1] [Reference Citation Analysis]
443 Zhao MX, Li JM, Du L, Tan CP, Xia Q, Mao ZW, Ji LN. Targeted cellular uptake and siRNA silencing by quantum-dot nanoparticles coated with β-cyclodextrin coupled to amino acids. Chemistry 2011;17:5171-9. [PMID: 21465588 DOI: 10.1002/chem.201003523] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
444 Kobayashi N, Matsui Y, Kawase A, Hirata K, Miyagishi M, Taira K, Nishikawa M, Takakura Y. Vector-based in vivo RNA interference: dose- and time-dependent suppression of transgene expression. J Pharmacol Exp Ther. 2004;308:688-693. [PMID: 14610223 DOI: 10.1124/jpet.103.059931] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
445 Liu X, Cao S, Zhou R, Xu G, Xiao S, Yang Y, Sun M, Li Y, Chen H. Inhibition of Japanese Encephalitis Virus NS1 Protein Expression in Cell by Small Interfering RNAs. Virus Genes 2006;33:69-75. [DOI: 10.1007/s11262-005-0039-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
446 Malphettes L, Fussenegger M. Macrolide- and tetracycline-adjustable siRNA-mediated gene silencing in mammalian cells using polymerase II-dependent promoter derivatives. Biotechnol Bioeng 2004;88:417-25. [PMID: 15382105 DOI: 10.1002/bit.20230] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
447 Nielsen TT, Marion IV, Hasholt L, Lundberg C. Neuron-specific RNA interference using lentiviral vectors. J Gene Med 2009;11:559-69. [DOI: 10.1002/jgm.1333] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
448 Korrapati AB, Swaminathan G, Singh A, Khanna N, Swaminathan S. Adenovirus delivered short hairpin RNA targeting a conserved site in the 5' non-translated region inhibits all four serotypes of dengue viruses. PLoS Negl Trop Dis 2012;6:e1735. [PMID: 22848770 DOI: 10.1371/journal.pntd.0001735] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
449 Dickins RA, Hemann MT, Zilfou JT, Simpson DR, Ibarra I, Hannon GJ, Lowe SW. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet 2005;37:1289-95. [PMID: 16200064 DOI: 10.1038/ng1651] [Cited by in Crossref: 383] [Cited by in F6Publishing: 375] [Article Influence: 23.9] [Reference Citation Analysis]
450 Svintradze DV, Mrevlishvili GM. Fiber molecular model of atelocollagen–small interfering RNA (siRNA) complex. International Journal of Biological Macromolecules 2005;37:283-6. [DOI: 10.1016/j.ijbiomac.2005.11.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
451 Ul Ain Q, Chung JY, Kim YH. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN. J Control Release. 2015;205:120-127. [PMID: 25553825 DOI: 10.1016/j.jconrel.2014.12.036] [Cited by in Crossref: 68] [Cited by in F6Publishing: 51] [Article Influence: 9.7] [Reference Citation Analysis]
452 Larsen SR, Rasko JE. Lymphoproliferative disorders: prospects for gene therapy. Pathology 2005;37:523-33. [DOI: 10.1080/00313020500402276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
453 Gitlin L, Andino R. Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing. J Virol 2003;77:7159-65. [PMID: 12805414 DOI: 10.1128/jvi.77.13.7159-7165.2003] [Cited by in Crossref: 97] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
454 Weinberg MS, Ely A, Passman M, Mufamadi SM, Arbuthnot P. Effective anti-hepatitis B virus hammerhead ribozymes derived from multimeric precursors. Oligonucleotides 2007;17:104-12. [PMID: 17461767 DOI: 10.1089/oli.2006.0049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
455 Chen LM, Le HY, Qin RY, Kumar M, Du ZY, Xia RJ, Deng J. Reversal of the phenotype by K-rasval12 silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1. World J Gastroenterol 2005;11:831-8. [PMID: 15682475 DOI: 10.3748/wjg.v11.i6.831] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
456 Kim EJ, Kramer SF, Hebert CG, Valdes JJ, Bentley WE. Metabolic engineering of the baculovirus-expression system via inverse “shotgun” genomic analysis and RNA interference (dsRNA) increases product yield and cell longevity. Biotechnol Bioeng 2007;98:645-54. [DOI: 10.1002/bit.21353] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
457 Sugiura K, Su YQ, Eppig JJ. Targeted suppression of Has2 mRNA in mouse cumulus cell-oocyte complexes by adenovirus-mediated short-hairpin RNA expression. Mol Reprod Dev 2009;76:537-47. [PMID: 18951380 DOI: 10.1002/mrd.20971] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
458 Zheng L, Liu J, Batalov S, Zhou D, Orth A, Ding S, Schultz PG. An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc Natl Acad Sci USA. 2004;101:135-140. [PMID: 14688408 DOI: 10.1073/pnas.2136685100] [Cited by in Crossref: 139] [Cited by in F6Publishing: 136] [Article Influence: 7.7] [Reference Citation Analysis]
459 Krom YD, Fallaux FJ, Que I, Lowik C, van Dijk KW. Efficient in vivo knock-down of estrogen receptor alpha: application of recombinant adenovirus vectors for delivery of short hairpin RNA. BMC Biotechnol 2006;6:11. [PMID: 16507095 DOI: 10.1186/1472-6750-6-11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
460 Choy EY, Kok K, Tsao SW, Jin D. Utility of Epstein–Barr virus-encoded small RNA promoters for driving the expression of fusion transcripts harboring short hairpin RNAs. Gene Ther 2008;15:191-202. [DOI: 10.1038/sj.gt.3303055] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
461 Moon JH, Kenry. Conjugated Polymers for Gene Delivery. In: Liu BL, editor. Conjugated Polymers for Biological and Biomedical Applications. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2018. pp. 215-41. [DOI: 10.1002/9783527342747.ch8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
462 Wu J, Nandamuri KM. Inhibition of hepatitis viral replication by siRNA. Expert Opin Biol Ther. 2004;4:1649-1659. [PMID: 15461576 DOI: 10.1517/14712598.4.10.1649] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
463 Drouet V, Perrin V, Hassig R, Dufour N, Auregan G, Alves S, Bonvento G, Brouillet E, Luthi-Carter R, Hantraye P, Déglon N. Sustained effects of nonallele-specific Huntingtin silencing. Ann Neurol 2009;65:276-85. [PMID: 19334076 DOI: 10.1002/ana.21569] [Cited by in Crossref: 162] [Cited by in F6Publishing: 149] [Article Influence: 13.5] [Reference Citation Analysis]
464 Wagner MJ, Mitra R, McArthur MJ, Baze W, Barnhart K, Wu SY, Rodriguez-Aguayo C, Zhang X, Coleman RL, Lopez-Berestein G, Sood AK. Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA). Mol Cancer Ther 2017;16:1114-23. [PMID: 28265009 DOI: 10.1158/1535-7163.MCT-16-0541] [Cited by in Crossref: 52] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
465 Shao W, Chen JB, Wang F, Xia JJ, Qi ZQ. Combined application of blocking antibodies and MicroRNA interference in inhibiting CD44 expression. Transplant Proc 2010;42:2777-81. [PMID: 20832586 DOI: 10.1016/j.transproceed.2010.05.149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
466 Takeshita F, Minakuchi Y, Nagahara S, Honma K, Sasaki H, Hirai K, Teratani T, Namatame N, Yamamoto Y, Hanai K, Kato T, Sano A, Ochiya T. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci U S A 2005;102:12177-82. [PMID: 16091473 DOI: 10.1073/pnas.0501753102] [Cited by in Crossref: 285] [Cited by in F6Publishing: 255] [Article Influence: 17.8] [Reference Citation Analysis]
467 Leung RK, Whittaker PA. RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol Ther. 2005;107:222-239. [PMID: 15908010 DOI: 10.1016/j.pharmthera.2005.03.004] [Cited by in Crossref: 240] [Cited by in F6Publishing: 196] [Article Influence: 15.0] [Reference Citation Analysis]
468 Xiong R, Samal SK, Demeester J, Skirtach AG, De Smedt SC, Braeckmans K. Laser-assisted photoporation: fundamentals, technological advances and applications. Advances in Physics: X 2016;1:596-620. [DOI: 10.1080/23746149.2016.1228476] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
469 Xue X, Lin J, Song Y, Sun X, Zhou H. RNA interference targeting leptin gene effect on hepatic stellate cells. J Huazhong Univ Sci Technolog Med Sci. 2005;25:655-657. [PMID: 16696317 DOI: 10.1007/BF02896162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
470 Sun L, Gao H, Sarma VJ, Guo RF, Ward PA. Adenovirus-mediated in vivo silencing of anaphylatoxin receptor C5aR. J Biomed Biotechnol 2006;2006:28945. [PMID: 17057363 DOI: 10.1155/JBB/2006/28945] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
471 Andino R. RNAi puts a lid on virus replication. Nat Biotechnol 2003;21:629-30. [PMID: 12776148 DOI: 10.1038/nbt0603-629] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
472 Lowenstein PR, Castro MG. Recent advances in the pharmacology of neurological gene therapy. Curr Opin Pharmacol 2004;4:91-7. [PMID: 15018845 DOI: 10.1016/j.coph.2003.10.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
473 Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA. 2003;9:493-501. [PMID: 12649500 DOI: 10.1261/rna.2192803] [Cited by in Crossref: 874] [Cited by in F6Publishing: 744] [Article Influence: 48.6] [Reference Citation Analysis]
474 Senn C, Hangartner C, Moes S, Guerini D, Hofbauer KG. Central administration of small interfering RNAs in rats: a comparison with antisense oligonucleotides. Eur J Pharmacol 2005;522:30-7. [PMID: 16213482 DOI: 10.1016/j.ejphar.2005.08.021] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
475 Sahare AA, Bedekar MK, Jain SK, Singh A, Singh S, Sarkhel BC. Inhibition of infectious bursal disease virus by vector delivered SiRNA in cell culture. Anim Biotechnol 2015;26:58-64. [PMID: 25153457 DOI: 10.1080/10495398.2014.886584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
476 Saleh M, Van Rij RP, Andino R. RNA silencing in viral infections: insights from poliovirus. Virus Research 2004;102:11-7. [DOI: 10.1016/j.virusres.2004.01.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
477 Chen Z, Krishnamachary B, Bhujwalla ZM. Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy. Nanomaterials (Basel) 2016;6:E34. [PMID: 28344291 DOI: 10.3390/nano6020034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
478 Herrera-Carrillo E, Liu YP, Berkhout B. Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors. Hum Gene Ther Methods 2017;28:177-90. [PMID: 28712309 DOI: 10.1089/hgtb.2017.036] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
479 Zhang H, Wang H, Zhang J, Qian G, Niu B, Fan X, Lu J, Hoffman AR, Hu JF, Ge S. Enhanced therapeutic efficacy by simultaneously targeting two genetic defects in tumors. Mol Ther 2009;17:57-64. [PMID: 19018252 DOI: 10.1038/mt.2008.236] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
480 Zhang J, Wang Y, Zhu P, Wang X, Lv M, Feng H. siRNA-mediated silence of protease-activated receptor-1 minimizes ischemic injury of cerebral cortex through HSP70 and MAP2. J Neurol Sci 2012;320:6-11. [PMID: 22831762 DOI: 10.1016/j.jns.2012.05.040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
481 Kasparov S, Teschemacher A, Hwang D, Kim K, Lonergan T, Paton J. Viral vectors as tools for studies of central cardiovascular control. Progress in Biophysics and Molecular Biology 2004;84:251-77. [DOI: 10.1016/j.pbiomolbio.2003.11.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
482 Gary DS, Davidson A, Milhavet O, Slunt H, Borchelt DR. Investigation of RNA interference to suppress expression of full-length and fragment human huntingtin. Neuromol Med 2007;9:145-55. [DOI: 10.1007/bf02685888] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
483 Wall NR, Shi Y. Small RNA: can RNA interference be exploited for therapy? Lancet. 2003;362:1401-1403. [PMID: 14585643 DOI: 10.1016/s0140-6736(03)14637-5] [Cited by in Crossref: 129] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
484 Hui EK, Yap EM, An DS, Chen ISY, Nayak DP. Inhibition of influenza virus matrix (M1) protein expression and virus replication by U6 promoter-driven and lentivirus-mediated delivery of siRNA. J Gen Virol 2004;85:1877-84. [PMID: 15218172 DOI: 10.1099/vir.0.79906-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
485 Mackay S, Smith RA. Effects of growth factors on testicular morphogenesis. Int Rev Cytol 2007;260:113-73. [PMID: 17482905 DOI: 10.1016/S0074-7696(06)60003-X] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
486 Zou G, Yoder MC. Application of RNA interference to study stem cell function: current status and future perspectives. Biology of the Cell 2005;97:211-9. [DOI: 10.1042/bc20040084] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
487 Nadworny AS, Guruju MR, Poor D, Doran RM, Sharma RV, Kotlikoff MI, Davisson RL. Nox2 and Nox4 influence neonatal c-kit(+) cardiac precursor cell status and differentiation. Am J Physiol Heart Circ Physiol 2013;305:H829-42. [PMID: 23832701 DOI: 10.1152/ajpheart.00761.2012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
488 Babcock AM, Standing D, Bullshields K, Schwartz E, Paden CM, Poulsen DJ. In vivo inhibition of hippocampal Ca2+/calmodulin-dependent protein kinase II by RNA interference. Mol Ther 2005;11:899-905. [PMID: 15922960 DOI: 10.1016/j.ymthe.2005.02.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
489 Ma Y, Chan CY, He ML. RNA interference and antiviral therapy. World J Gastroenterol 2007;13:5169-79. [PMID: 17876887 DOI: 10.3748/wjg.v13.i39.5169] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
490 Gao LF, Xu DQ, Wen LJ, Zhang XY, Shao YT, Zhao XJ. Inhibition of STAT3 expression by siRNA suppresses growth and induces apoptosis in laryngeal cancer cells. Acta Pharmacol Sin 2005;26:377-83. [PMID: 15715937 DOI: 10.1111/j.1745-7254.2005.00053.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
491 Song J, Pang S, Lu Y, Chiu R. Poly(U) and polyadenylation termination signals are interchangeable for terminating the expression of shRNA from a pol II promoter. Biochem Biophys Res Commun 2004;323:573-8. [PMID: 15369789 DOI: 10.1016/j.bbrc.2004.08.128] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
492 Lee JK, Lee DH, Sun EG, Bae JA, Lim SC, Min JJ, Sung MW, Kim KK. Gene therapy for head and neck squamous cell carcinoma using KITENIN (KAI1 COOH-Terminal Interacting Tetraspanin)-antisense therapy. Yonsei Med J 2011;52:463-8. [PMID: 21488189 DOI: 10.3349/ymj.2011.52.3.463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
493 Smith RA, Miller TM, Yamanaka K, Monia BP, Condon TP, Hung G, Lobsiger CS, Ward CM, McAlonis-Downes M, Wei H, Wancewicz EV, Bennett CF, Cleveland DW. Antisense oligonucleotide therapy for neurodegenerative disease. J Clin Invest 2006;116:2290-6. [PMID: 16878173 DOI: 10.1172/JCI25424] [Cited by in Crossref: 317] [Cited by in F6Publishing: 171] [Article Influence: 21.1] [Reference Citation Analysis]
494 Ferreiro I, Genevois C, Konate K, Vivès E, Boisguérin P, Deshayes S, Couillaud F. In Vivo Follow-Up of Gene Inhibition in Solid Tumors Using Peptide-Based Nanoparticles for siRNA Delivery. Pharmaceutics 2021;13:749. [PMID: 34069377 DOI: 10.3390/pharmaceutics13050749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
495 Greber D, Fussenegger M. Multi-gene engineering: Simultaneous expression and knockdown of six genes off a single platform. Biotechnol Bioeng 2007;96:821-34. [DOI: 10.1002/bit.21303] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
496 Bruno K. Using drug-excipient interactions for siRNA delivery. Adv Drug Deliv Rev 2011;63:1210-26. [PMID: 21945846 DOI: 10.1016/j.addr.2011.09.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
497 Lei L, Han D, Gong S, Zheng J, Xu J. Mpz gene suppression by shRNA increases Schwann cell apoptosis in vitro. Neurol Sci 2010;31:603-8. [PMID: 20552241 DOI: 10.1007/s10072-010-0341-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
498 Sun Z. Overview of recent advances in molecular cardiology. Can J Cardiol 2006;22:235-40. [PMID: 16520855 DOI: 10.1016/s0828-282x(06)70903-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
499 Svintradze DV, Mrevlishvili GM, Metreveli N, Jariashvili K, Namicheishvili L, Skopinska J, Sionkowska A. Collagen-DNA complex. Biomacromolecules 2008;9:21-8. [PMID: 18052128 DOI: 10.1021/bm7008813] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
500 Wadhwa R, Kaul SC, Miyagishi M, Taira K. Know-how of RNA interference and its applications in research and therapy. Mutat Res. 2004;567:71-84. [PMID: 15341903 DOI: 10.1016/j.mrrev.2004.06.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
501 Huang SL, Wu Y, Yu H, Zhang P, Zhang XQ, Ying L, Zhao HF. Inhibition of Bcl-2 expression by a novel tumor-specific RNA interference system increases chemosensitivity to 5-fluorouracil in Hela cells. Acta Pharmacol Sin. 2006;27:242-248. [PMID: 16412276 DOI: 10.1111/j.1745-7254.2006.00247.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
502 Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med. 2003;9:347-351. [PMID: 12579197 DOI: 10.1038/nm828] [Cited by in Crossref: 805] [Cited by in F6Publishing: 705] [Article Influence: 44.7] [Reference Citation Analysis]
503 Zulliger R, Conley SM, Naash MI. Non-viral therapeutic approaches to ocular diseases: An overview and future directions. J Control Release 2015;219:471-87. [PMID: 26439665 DOI: 10.1016/j.jconrel.2015.10.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
504 Witting SR, Brown M, Saxena R, Nabinger S, Morral N. Helper-dependent Adenovirus-mediated Short Hairpin RNA Expression in the Liver Activates the Interferon Response. Journal of Biological Chemistry 2008;283:2120-8. [DOI: 10.1074/jbc.m704178200] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
505 Ying SY, Chang CP, Lin SL. Intron-mediated RNA interference, intronic microRNAs, and applications. Methods Mol Biol 2010;629:205-37. [PMID: 20387152 DOI: 10.1007/978-1-60761-657-3_14] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
506 Scholefield J, Wood MJ. Therapeutic gene silencing strategies for polyglutamine disorders. Trends in Genetics 2010;26:29-38. [DOI: 10.1016/j.tig.2009.11.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
507 Nagano A, Ohno T, Shimizu K, Hara A, Yamamoto T, Kawai G, Saitou M, Takigami I, Matsuhashi A, Yamada K, Takei Y. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A. Int J Cancer 2010;126:2790-8. [PMID: 19642105 DOI: 10.1002/ijc.24781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.2] [Reference Citation Analysis]
508 Mikhaylova M, Stasinopoulos I, Kato Y, Artemov D, Bhujwalla ZM. Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA. Cancer Gene Ther 2009;16:217-26. [PMID: 18927599 DOI: 10.1038/cgt.2008.79] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
509 Godfrey A, Anderson J, Papanastasiou A, Takeuchi Y, Boshoff C. Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood 2005;105:2510-8. [DOI: 10.1182/blood-2004-08-3052] [Cited by in Crossref: 129] [Cited by in F6Publishing: 119] [Article Influence: 8.1] [Reference Citation Analysis]
510 Giannoukakis N, Trucco M. Gene therapy for type 1 diabetes. Am J Ther. 2005;12:512-528. [PMID: 16280645 DOI: 10.1097/01.mjt.0000178774.39149.2d] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
511 Hutson TH, Foster E, Dawes JM, Hindges R, Yáñez-Muñoz RJ, Moon LD. Lentiviral vectors encoding short hairpin RNAs efficiently transduce and knockdown LINGO-1 but induce an interferon response and cytotoxicity in central nervous system neurones. J Gene Med 2012;14:299-315. [PMID: 22499506 DOI: 10.1002/jgm.2626] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
512 Zhang B, Farwell MA. microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med 2008;12:3-21. [PMID: 18088390 DOI: 10.1111/j.1582-4934.2007.00196.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 6.4] [Reference Citation Analysis]
513 de Bruyns A, Geiling B, Dankort D. Construction of Modular Lentiviral Vectors for Effective Gene Expression and Knockdown. In: Federico M, editor. Lentiviral Vectors and Exosomes as Gene and Protein Delivery Tools. New York: Springer; 2016. pp. 3-21. [DOI: 10.1007/978-1-4939-3753-0_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
514 Boudreau RL, Rodríguez-Lebrón E, Davidson BL. RNAi medicine for the brain: progresses and challenges. Hum Mol Genet 2011;20:R21-7. [PMID: 21459775 DOI: 10.1093/hmg/ddr137] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
515 Zhang J, Yamada O, Sakamoto T, Yoshida H, Araki H, Shimotohno K. Exploiting cis-acting replication elements to direct hepatitis C virus-dependent transgene expression. J Virol 2005;79:5923-32. [PMID: 15857978 DOI: 10.1128/JVI.79.10.5923-5932.2005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
516 Rutz S, Scheffold A. Towards in vivo application of RNA interference - new toys, old problems. Arthritis Res Ther 2004;6:78-85. [PMID: 15059269 DOI: 10.1186/ar1168] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
517 Deveraux QL, Aza-Blanc P, Wagner KW, Bauerschlag D, Cooke MP, Hampton GM. Exposing oncogenic dependencies for cancer drug target discovery and validation using RNAi. Semin Cancer Biol 2003;13:293-300. [PMID: 14563124 DOI: 10.1016/s1044-579x(03)00043-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
518 Cockrell AS, Kafri T. Gene delivery by lentivirus vectors. Mol Biotechnol. 2007;36:184-204. [PMID: 17873406 DOI: 10.1007/s12033-007-0010-8] [Cited by in Crossref: 209] [Cited by in F6Publishing: 167] [Article Influence: 14.9] [Reference Citation Analysis]
519 Zhang M, Koskie K, Ross JS, Kayser KJ, Caple MV. Enhancing glycoprotein sialylation by targeted gene silencing in mammalian cells. Biotechnol Bioeng 2010;105:1094-105. [PMID: 20014139 DOI: 10.1002/bit.22633] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
520 Chen Q, Butler D, Querbes W, Pandey RK, Ge P, Maier MA, Zhang L, Rajeev KG, Nechev L, Kotelianski V, Manoharan M, Sah DW. Lipophilic siRNAs mediate efficient gene silencing in oligodendrocytes with direct CNS delivery. J Control Release 2010;144:227-32. [PMID: 20170694 DOI: 10.1016/j.jconrel.2010.02.011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
521 Wu Q, Wang K, Wang X, Liang G, Li J. Delivering siRNA to control osteogenic differentiation and real-time detection of cell differentiation in human mesenchymal stem cells using multifunctional gold nanoparticles. J Mater Chem B 2020;8:3016-27. [DOI: 10.1039/c9tb02899d] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
522 Sakamoto N, Tanabe Y, Yokota T, Satoh K, Sekine-Osajima Y, Nakagawa M, Itsui Y, Tasaka M, Sakurai Y, Cheng-Hsin C, Yano M, Ohkoshi S, Aoyagi Y, Maekawa S, Enomoto N, Kohara M, Watanabe M. Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA. J Gastroenterol Hepatol 2008;23:1437-47. [PMID: 17683479 DOI: 10.1111/j.1440-1746.2007.05076.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
523 Sonwane AA, Dahiya SS, Saini M, Chaturvedi V, Singh R, Gupta PK. Inhibition of rabies virus multiplication by siRNA delivered through adenoviral vector in vitro in BHK-21 cells and in vivo in mice. Research in Veterinary Science 2012;93:498-503. [DOI: 10.1016/j.rvsc.2011.06.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
524 Rhodes K, Clark I, Zatcoff M, Eustaquio T, Hoyte KL, Koller MR. Cellular laserfection. Methods Cell Biol 2007;82:309-33. [PMID: 17586262 DOI: 10.1016/S0091-679X(06)82010-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
525 Kiani S, Beal J, Ebrahimkhani MR, Huh J, Hall RN, Xie Z, Li Y, Weiss R. CRISPR transcriptional repression devices and layered circuits in mammalian cells. Nat Methods 2014;11:723-6. [PMID: 24797424 DOI: 10.1038/nmeth.2969] [Cited by in Crossref: 144] [Cited by in F6Publishing: 110] [Article Influence: 20.6] [Reference Citation Analysis]
526 Cashman SM, Binkley EA, Kumar-Singh R. Towards mutation-independent silencing of genes involved in retinal degeneration by RNA interference. Gene Ther 2005;12:1223-8. [PMID: 15877050 DOI: 10.1038/sj.gt.3302512] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
527 Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol. 2003;5:834-839. [PMID: 12942087 DOI: 10.1038/ncb1038] [Cited by in Crossref: 994] [Cited by in F6Publishing: 899] [Article Influence: 55.2] [Reference Citation Analysis]
528 Harper SQ, Staber PD, Beck CR, Fineberg SK, Stein C, Ochoa D, Davidson BL. Optimization of feline immunodeficiency virus vectors for RNA interference. J Virol. 2006;80:9371-9380. [PMID: 16973543 DOI: 10.1128/JVI.00958-06] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
529 Cao HB, Wang A, Martin B, Koehler DR, Zeitlin PL, Tanawell AK, Hu J. Down-regulation of IL-8 expression in human airway epithelial cells through helper-dependent adenoviral-mediated RNA interference. Cell Res 2005;15:111-9. [PMID: 15740640 DOI: 10.1038/sj.cr.7290275] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
530 Chu L, Gu J, Sun L, Qian Q, Qian C, Liu X. Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil. Gene Ther. 2008;15:484-494. [PMID: 18239605 DOI: 10.1038/gt.2008.6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
531 Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003;4:346-358. [PMID: 12728277 DOI: 10.1038/nrg1066] [Cited by in Crossref: 1676] [Cited by in F6Publishing: 1417] [Article Influence: 93.1] [Reference Citation Analysis]
532 Shi Y. Mammalian RNAi for the masses. Trends Genet. 2003;19:9-12. [PMID: 12493242 DOI: 10.1016/s0168-9525(02)00005-7] [Cited by in Crossref: 203] [Cited by in F6Publishing: 65] [Article Influence: 11.3] [Reference Citation Analysis]
533 Keiser MS, Geoghegan JC, Boudreau RL, Lennox KA, Davidson BL. RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1. Neurobiol Dis 2013;56:6-13. [PMID: 23583610 DOI: 10.1016/j.nbd.2013.04.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
534 Read ML, Farrow PJ, Seymour LW. Emerging developments in RNA therapeutics. Expert Opin Ther Targets 2003;7:299-303. [PMID: 12667105 DOI: 10.1517/14728222.7.2.299] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
535 Xiuzhu T, Shore L, Stram Y, Michaeli S, Brietbart H, Shemesh M. Duplexes of 21 nucleotide RNA specific for COX II mediates RNA interference in cultured bovine aortic coronary endothelial cells (BAECs). Prostaglandins & Other Lipid Mediators 2003;71:119-29. [DOI: 10.1016/s1098-8823(03)00043-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
536 Gomez CM, Subramony S. Dominantly inherited ataxias. Seminars in Pediatric Neurology 2003;10:210-22. [DOI: 10.1016/s1071-9091(03)00030-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
537 Li W, Tao S, Wu Q, Wu T, Tao R, Fan J. Glutamine reduces myocardial cell apoptosis in a rat model of sepsis by promoting expression of heat shock protein 90. Journal of Surgical Research 2017;220:247-54. [DOI: 10.1016/j.jss.2017.06.090] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
538 Unwalla HJ, Li HT, Bahner I, Li MJ, Kohn D, Rossi JJ. Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein. J Virol 2006;80:1863-73. [PMID: 16439542 DOI: 10.1128/JVI.80.4.1863-1873.2006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
539 Mizuguchi H, Funakoshi N, Hosono T, Sakurai F, Kawabata K, Yamaguchi T, Hayakawa T. Rapid Construction of Small Interfering RNA-Expressing Adenoviral Vectors on the Basis of Direct Cloning of Short Hairpin RNA-Coding DNAs. Human Gene Therapy 2007;18:74-80. [DOI: 10.1089/hum.2006.129] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
540 Aliabadi HM, Landry B, Sun C, Tang T, Uludağ H. Supramolecular assemblies in functional siRNA delivery: Where do we stand? Biomaterials 2012;33:2546-69. [DOI: 10.1016/j.biomaterials.2011.11.079] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 11.4] [Reference Citation Analysis]
541 Davidson BL, McCray PB. Current prospects for RNA interference-based therapies. Nat Rev Genet. 2011;12:329-340. [PMID: 21499294 DOI: 10.1038/nrg2968] [Cited by in Crossref: 528] [Cited by in F6Publishing: 448] [Article Influence: 52.8] [Reference Citation Analysis]
542 Hoyer D, Thakker DR, Natt F, Maier R, Huesken D, Müller M, Flor P, Van Der Putten H, Schmutz M, Bilbe G, Cryan JF. Global Down-Regulation of Gene Expression in the Brain Using RNA Interference, with Emphasis on Monoamine Transporters and GPCRs: Implications for Target Characterization in Psychiatric and Neurological Disorders. Journal of Receptors and Signal Transduction 2008;26:527-47. [DOI: 10.1080/10799890600929663] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
543 Sen A, Steele R, Ghosh AK, Basu A, Ray R, Ray RB. Inhibition of hepatitis C virus protein expression by RNA interference. Virus Res 2003;96:27-35. [PMID: 12951263 DOI: 10.1016/s0168-1702(03)00170-9] [Cited by in Crossref: 49] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
544 Mack SO, Wu M, Kc P, Haxhiu MA. Stimulation of the hypothalamic paraventricular nucleus modulates cardiorespiratory responses via oxytocinergic innervation of neurons in pre-Botzinger complex. J Appl Physiol (1985) 2007;102:189-99. [PMID: 16857863 DOI: 10.1152/japplphysiol.00522.2006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
545 Unwalla HJ, Rossi JJ. Screening effective target sites on mRNA: a ribozyme library approach. Methods Mol Biol 2012;848:329-36. [PMID: 22315078 DOI: 10.1007/978-1-61779-545-9_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
546 Miller H, Grollman AP. DNA repair investigations using siRNA. DNA Repair (Amst) 2003;2:759-63. [PMID: 12767354 DOI: 10.1016/s1568-7864(03)00042-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
547 Crnkovic-Mertens I, Hoppe-Seyler F, Butz K. Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene. 2003;22:8330-8336. [PMID: 14614456 DOI: 10.1038/sj.onc.1206973] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
548 Berhanu D, Rush R. Targeted silencing of TrkA expression in rat forebrain neurons via the p75 receptor. Neuroscience 2008;153:1115-25. [DOI: 10.1016/j.neuroscience.2008.03.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
549 Sioud M. On the delivery of small interfering RNAs into mammalian cells. Expert Opin Drug Deliv 2005;2:639-51. [PMID: 16296791 DOI: 10.1517/17425247.2.4.639] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
550 Sakai T, Kawaguchi M, Kosuge Y. siRNA-mediated gene silencing in the salivary gland using in vivo microbubble-enhanced sonoporation. Oral Dis 2009;15:505-11. [PMID: 19519620 DOI: 10.1111/j.1601-0825.2009.01579.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
551 Wood MJA, Trulzsch B, Abdelgany A, Beeson D. Therapeutic gene silencing in the nervous system. Human Molecular Genetics 2012;12:R279-84. [DOI: 10.1093/hmg/ddg275] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
552 Conklin DS. RNA-Interference-Based Silencing of Mammalian Gene Expression. ChemBioChem 2003;4:1033-9. [DOI: 10.1002/cbic.200300686] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
553 Li T, Folkesson HG. RNA interference for alpha-ENaC inhibits rat lung fluid absorption in vivo. Am J Physiol Lung Cell Mol Physiol 2006;290:L649-60. [PMID: 16258001 DOI: 10.1152/ajplung.00205.2005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
554 Tong AW, Nemunaitis J. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther. 2008;15:341-355. [PMID: 18369380 DOI: 10.1038/cgt.2008.8] [Cited by in Crossref: 159] [Cited by in F6Publishing: 145] [Article Influence: 12.2] [Reference Citation Analysis]
555 Centanni TM, Chen F, Booker AM, Engineer CT, Sloan AM, Rennaker RL, LoTurco JJ, Kilgard MP. Speech sound processing deficits and training-induced neural plasticity in rats with dyslexia gene knockdown. PLoS One 2014;9:e98439. [PMID: 24871331 DOI: 10.1371/journal.pone.0098439] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
556 Van Ba H, Inho H. Significant role of μ-calpain (CANP1) in proliferation/survival of bovine skeletal muscle satellite cells. In Vitro Cell Dev Biol Anim 2013;49:785-97. [PMID: 23943438 DOI: 10.1007/s11626-013-9666-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
557 Huang G, Elferink CJ. Multiple mechanisms are involved in Ah receptor-mediated cell cycle arrest. Mol Pharmacol 2005;67:88-96. [PMID: 15492120 DOI: 10.1124/mol.104.002410] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 4.6] [Reference Citation Analysis]
558 Rozema DB, Lewis DL, Wakefield DH, Wong SC, Klein JJ, Roesch PL, Bertin SL, Reppen TW, Chu Q, Blokhin AV, Hagstrom JE, Wolff JA. Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci U S A 2007;104:12982-7. [PMID: 17652171 DOI: 10.1073/pnas.0703778104] [Cited by in Crossref: 498] [Cited by in F6Publishing: 438] [Article Influence: 35.6] [Reference Citation Analysis]
559 Yang ZF, Sun Y, Li CZ, Wang HW, Wang XJ, Zheng YQ, Liu K, Liu YM. Reduced sinoatrial cAMP content plays a role in postnatal heart rate slowing in the rabbit. Clin Exp Pharmacol Physiol. 2006;33:757-762. [PMID: 16895552 DOI: 10.1111/j.1440-1681.2006.04408.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
560 Patel C, Muthuswamy J. High efficiency, site-specific transfection of adherent cells with siRNA using microelectrode arrays (MEA). J Vis Exp 2012;:e4415. [PMID: 23007885 DOI: 10.3791/4415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
561 Dykxhoorn DM, Novina CD, Sharp PA. Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol. 2003;4:457-467. [PMID: 12778125 DOI: 10.1038/nrm1129] [Cited by in Crossref: 771] [Cited by in F6Publishing: 689] [Article Influence: 42.8] [Reference Citation Analysis]